UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
X |
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2006. | ||
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO _____________. | ||
|
Commission File Number: 1-8403 | ||
ENERGY CONVERSION DEVICES, INC. | |||
(Exact name of registrant as specified in its charter) | |||
DELAWARE |
38-1749884 | ||
(State or other jurisdiction of incorporation) |
(I.R.S. Employer Identification No.) | ||
2956 Waterview Drive, Rochester Hills, Michigan |
48309 | ||
(Address of principal executive offices) |
(Zip Code) | ||
Registrant's telephone number, including area code |
(248) 293-0440 | ||
| |||
Former name, former address and former fiscal year, if changed since last report. | |||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer [ X ] |
Accelerated filer [ ] |
Non-accelerated filer [ ] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ X ]
As of May 5, 2006, there were 39,046,240 shares of ECD's Common Stock outstanding.
Page 1 of 51 Pages
ENERGY CONVERSION DEVICES, INC. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
TABLE OF CONTENTS
2
Table of Contents
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
REVENUES | ||||||||||||
Product sales | $ | 21,401,379 | $ | 13,449,653 | $ | 62,348,992 | $ | 36,316,802 | ||||
Royalties | 1,703,837 | 670,128 | 3,218,083 | 3,746,342 | ||||||||
Revenues from product development agreements | 3,146,206 | 2,901,312 | 6,770,139 | 9,073,182 | ||||||||
Revenues from product development | ||||||||||||
agreements with related parties | 120,936 | 460,586 | 677,508 | 5,616,777 | ||||||||
Total revenues from product development | ||||||||||||
agreements | 3,267,142 | 3,361,898 | 7,447,647 | 14,689,959 | ||||||||
Revenues from license and other agreements | 288,080 | 238,095 | 784,270 | 80,246,285 | ||||||||
Other revenues | 54,293 | 80,169 | 109,274 | 414,485 | ||||||||
Other revenues from related parties | 242,577 | 95,660 | 581,376 | 247,963 | ||||||||
Total other revenues | 296,870 | 175,829 | 690,650 | 662,448 | ||||||||
TOTAL REVENUES | 26,957,308 | 17,895,603 | 74,489,642 | 135,661,836 | ||||||||
EXPENSES | ||||||||||||
Cost of product sales | 16,526,482 | 12,593,127 | 50,075,143 | 38,263,757 | ||||||||
Cost of revenues from product development | ||||||||||||
agreements | 2,786,423 | 3,229,416 | 6,589,430 | 13,345,812 | ||||||||
Product development and research | 8,757,646 | 7,102,601 | 25,035,349 | 19,991,759 | ||||||||
Patents | 693,270 | 711,718 | 1,902,501 | 2,089,184 | ||||||||
Operating, general and administrative (net) | 5,647,002 | 5,544,803 | 12,187,877 | 11,354,740 | ||||||||
TOTAL EXPENSES | 34,410,823 | 29,181,665 | 95,790,300 | 85,045,252 | ||||||||
INCOME (LOSS) FROM OPERATIONS | (7,453,515 | ) | (11,286,062 | ) | (21,300,658 | ) | 50,616,584 | |||||
OTHER INCOME (EXPENSE) | ||||||||||||
Interest income | 1,932,808 | 409,019 | 3,530,362 | 594,552 | ||||||||
Interest expense | | (70,364 | ) | (197,332 | ) | (541,170 | ) | |||||
Equity in losses of joint ventures | (105,000 | ) | | (150,000 | ) | (100,000 | ) | |||||
Impairment loss in Rare Earth Ovonic-China | | | | (1,710,000 | ) | |||||||
Distribution from joint venture | | | | 8,000,000 | ||||||||
Other nonoperating income (expense) | (328 | ) | (196,141 | ) | (23,627 | ) | 76,989 | |||||
TOTAL OTHER INCOME (EXPENSE) | 1,827,480 | 142,514 | 3,159,403 | 6,320,371 | ||||||||
NET INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES AND EXTRAORDINARY ITEM |
(5,626,035 | ) | (11,143,548 | ) | (18,141,255 | ) | 56,936,955 | |||||
INCOME TAXES (Benefit) | | (198,136 | ) | | 826,864 | |||||||
NET INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE EXTRAORDINARY ITEM |
(5,626,035 | ) | (10,945,412 | ) | (18,141,255 | ) | 56,110,091 | |||||
DISCONTINUED OPERATIONS (including gain on | ||||||||||||
disposition of discontinued operations of $739,602 | ||||||||||||
in the nine months ended March 31, 2006) | | (304,576 | ) | 313,979 | (1,141,141 | ) | ||||||
EXTRAORDINARY ITEM (net of taxes) | | | | 2,266,326 | ||||||||
NET INCOME (LOSS) | $ | (5,626,035 | ) | $ | (11,249,988 | ) | $ | (17,827,276 | ) | $ | 57,235,276 | |
BASIC NET INCOME (LOSS) PER SHARE | ||||||||||||
CONTINUING OPERATIONS | $ | (.17 | ) | $ | (.38 | ) | $ | (.60 | ) | $ | 2.12 | |
DISCONTINUED OPERATIONS | | (.01 | ) | .01 | (.04 | ) | ||||||
EXTRAORDINARY ITEM | | | | .08 | ||||||||
BASIC NET INCOME (LOSS) PER SHARE | $ | (.17 | ) | $ | (.39 | ) | $ | (.59 | ) | $ | 2.16 | |
DILUTED NET INCOME (LOSS) PER SHARE | ||||||||||||
CONTINUING OPERATIONS | $ | (.17 | ) | $ | (.38 | ) | $ | (.60 | ) | $ | 2.04 | |
DISCONTINUED OPERATIONS | | (.01 | ) | .01 | (.04 | ) | ||||||
EXTRAORDINARY ITEM | | | | .08 | ||||||||
DILUTED NET INCOME (LOSS) PER SHARE | $ | (.17 | ) | $ | (.39 | ) | $ | (.59 | ) | $ | 2.08 |
See notes to consolidated financial statements.
3
Table of Contents
See notes to consolidated financial statements.
4
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' EQUITY
March 31, 2006 | June 30, 2005 |
|||||||||||
(Unaudited) | ||||||||||||
CURRENT LIABILITIES | ||||||||||||
Accounts payable and accrued expenses | $ | 21,108,129 | $ | 15,914,518 | ||||||||
Salaries, wages and amounts withheld from employees | 3,299,042 | 4,368,205 | ||||||||||
Deferred revenues under business agreements | 312,634 | 1,288,268 | ||||||||||
Current portion of deferred patent license fee | 952,380 | 952,380 | ||||||||||
Current installments on long-term liabilities | 455,603 | 369,010 | ||||||||||
TOTAL CURRENT LIABILITIES | 26,127,788 | 22,892,381 | ||||||||||
LONG-TERM LIABILITIES | 10,167,541 | 10,203,772 | ||||||||||
LONG-TERM DEFERRED PATENT LICENSE FEE | 7,380,955 | 8,095,240 | ||||||||||
NONREFUNDABLE ADVANCE ROYALTIES | 459,462 | 1,151,679 | ||||||||||
TOTAL LIABILITIES | 44,135,746 | 42,343,072 | ||||||||||
COMMITMENTS (NOTE G) | ||||||||||||
STOCKHOLDERS' EQUITY | ||||||||||||
Capital Stock | ||||||||||||
Class A Convertible Common Stock, | ||||||||||||
par value $0.01 per share: | ||||||||||||
Authorized zero shares at March 31, 2006 and | ||||||||||||
500,000 shares at June 30, 2005 | ||||||||||||
Issued & outstanding zero shares at March 31, | ||||||||||||
2006 and 219,913 shares at June 30, 2005 | | 2,199 | ||||||||||
Class B Convertible Common Stock, | ||||||||||||
par value $0.01 per share: | ||||||||||||
Authorized, issued and outstanding - zero | ||||||||||||
shares at March 31, 2006 and 430,000 | ||||||||||||
shares at June 30, 2005 | | 4,300 | ||||||||||
Common Stock, par value $0.01 per share: | ||||||||||||
Authorized - 50,000,000 shares | ||||||||||||
Issued and outstanding 37,978,980 shares at | ||||||||||||
March 31, 2006 and 28,232,970 shares | ||||||||||||
at June 30, 2005 | 379,790 | 282,330 | ||||||||||
Additional paid-in capital | 790,843,513 | 440,577,239 | ||||||||||
Accumulated deficit | (303,018,629 | ) | (285,191,353 | ) | ||||||||
Accumulated other comprehensive income (loss) | (58,580 | ) | 211,586 | |||||||||
Unearned compensation on Class B Convertible | ||||||||||||
Common Stock | | (165,940 | ) | |||||||||
TOTAL STOCKHOLDERS' EQUITY | 488,146,094 | 155,720,361 | ||||||||||
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY | $ | 532,281,840 | $ | 198,063,433 |
See notes to consolidated financial statements.
5
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended March 31, | ||||||||||||
2006 | 2005 | |||||||||||
OPERATING ACTIVITIES: | ||||||||||||
Net income (loss) | $ | (17,827,276 | ) | $ | 57,235,276 | |||||||
Adjustments to reconcile net income (loss) to net cash | ||||||||||||
used in operating activities: | ||||||||||||
Depreciation and amortization | 5,584,780 | 6,012,866 | ||||||||||
Depreciation on discontinued operations | | 57,570 | ||||||||||
Bad debt expense | 261,116 | 276,308 | ||||||||||
Amortization of deferred nonrefundable patent license fee | (714,285 | ) | (714,285 | ) | ||||||||
Amortization of premium/discount on investments | (2,759 | ) | | |||||||||
Equity in losses of joint ventures | 150,000 | 100,000 | ||||||||||
Impairment loss in Rare Earth Ovonic | | 1,710,000 | ||||||||||
Change in nonrefundable advance royalties | (692,217 | ) | (1,830,302 | ) | ||||||||
Stock and stock options issued for services rendered | 1,970,452 | 786,242 | ||||||||||
Gain on sales of discontinued operations | (739,602 | ) | | |||||||||
(Gain)/Loss on sale of property, plant and equipment | (35,127 | ) | 5,383 | |||||||||
Retirement liability | 159,798 | 249,408 | ||||||||||
Option received in exchange for license | | (79,532,000 | ) | |||||||||
Changes in working capital: | ||||||||||||
Reduction in restricted cash | | 350,000 | ||||||||||
Accounts receivable | (4,411,795 | ) | (338,454 | ) | ||||||||
Inventories | (3,123,188 | ) | (1,356,628 | ) | ||||||||
Other assets | (1,429,719 | ) | (134,664 | ) | ||||||||
Current portion of deferred nonrefundable patent license fee | | 952,380 | ||||||||||
Accounts payable and accrued expenses | 4,124,448 | 442,627 | ||||||||||
Deferred revenues under business agreements | (975,634 | ) | 516,360 | |||||||||
Deferred nonrefundable patent license fee | | 9,047,620 | ||||||||||
NET CASH USED IN OPERATING ACTIVITIES | (17,701,008 | ) | (6,164,293 | ) | ||||||||
INVESTING ACTIVITIES: | ||||||||||||
Purchases of property, plant, and equipment (including construction in progress) | (40,446,527 | ) | (1,044,439 | ) | ||||||||
Purchases of investments | (107,097,042 | ) | (19,768,819 | ) | ||||||||
Investment in Ovonyx | (150,000 | ) | (100,000 | ) | ||||||||
Proceeds from maturities of investments | 13,820,051 | | ||||||||||
Proceeds from sale of discontinued operations | 891,887 | | ||||||||||
Proceeds from sale of property, plant and equipment | 37,930 | 15,065 | ||||||||||
NET CASH USED IN INVESTING ACTIVITIES | (132,943,701 | ) | (20,898,193 | ) | ||||||||
FINANCING ACTIVITIES: | ||||||||||||
Principal payments under short-term and long-term debt | ||||||||||||
obligations and capitalized lease obligations | (109,436 | ) | (246,825 | ) | ||||||||
Proceeds from exercise of stock options | 18,791,273 | 12,216,297 | ||||||||||
Proceeds from sale of stock and warrants, net of expenses | 329,761,451 | 82,186,817 | ||||||||||
NET CASH PROVIDED BY FINANCING ACTIVITIES | 348,443,288 | 94,156,289 | ||||||||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND | ||||||||||||
CASH EQUIVALENTS | (259,557 | ) | 101,679 | |||||||||
NET INCREASE IN CASH AND CASH EQUIVALENTS | 197,539,022 | 67,195,482 | ||||||||||
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 84,295,571 | 12,676,537 | ||||||||||
CASH AND CASH EQUIVALENTS AT END OF PERIOD | $ | 281,834,593 | $ | 79,872,019 |
See notes to consolidated financial statements.
6
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended March 31, | ||||||||||||
2006 | 2005 | |||||||||||
SUPPLEMENTAL DISCLOSURES OF | ||||||||||||
CASH FLOW INFORMATION: | ||||||||||||
Cash paid for interest | $ | 899,938 | $ | 541,170 | ||||||||
Amounts due from sale of assets | 438,887 | | ||||||||||
Cash paid for income taxes | 707,302 | |
See notes to consolidated financial statements.
7
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies
Basis of Presentation
In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial statements for the interim periods have been included. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the Securities and Exchange Commissions rules and regulations. The Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Companys latest annual report on Form 10-K, as amended, which is available on the Companys website www.ovonic.com.
Nature of Business
Energy Conversion Devices, Inc. (ECD) is a technology, product development and manufacturing company engaged in the invention, engineering, development and commercialization of new materials, products and production technology in the fields of alternative energy and information technologies.
Financial Statement Presentation, Principles of Consolidation and Equity Accounting
The consolidated financial statements include the accounts of ECD and its 100%-owned manufacturing and sales subsidiaries United Solar Ovonic Corp. and United Solar Ovonic LLC (jointly referred to as United Solar Ovonic) and its approximately 91%-owned subsidiary Ovonic Battery Company, Inc. (Ovonic Battery) (collectively the "Company"). No minority interest related to Ovonic Battery is recorded in the consolidated financial statements because there is no additional funding requirement by the minority shareholders. The Company has a number of strategic alliances and, as of March 31, 2006, has two major investments accounted for using the equity method: (i) Cobasys LLC, a joint venture between Ovonic Battery and a subsidiary of Chevron Corporation, Chevron Technology Ventures LLC, (Chevron), each having 50% interest in the joint venture and (ii) Ovonyx, Inc., a 39.5%-owned corporation with Mr. Tyler Lowrey, Intel Capital and other investors. See Note E for discussions of all of the Companys major joint ventures and investments.
Discontinued Operations
In June 2005, the Company, as part of its restructuring plan, decided to sell the assets of Ovonic Battery's metal hydride materials manufacturing business.
8
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
At June 30, 2005, the Company reclassified the current net book value of these fixed assets as assets held for sale and ceased depreciating these assets.
For the three months and nine months ended March 31, 2006 and 2005, the Company has recorded the following results of its metal hydride materials manufacturing business as a discontinued operation in accordance with Statement of Financial Accounting Standards (SFAS) No. 144:
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Revenues | $ | | $ | 45,973 | $ | 54,788 | $ | 155,429 | ||||
Costs and expenses | | (350,549 | ) | (480,411 | ) | (1,296,570 | ) | |||||
Gain on disposition of discontinued operations | | | 739,602 | | ||||||||
Net income (loss) from discontinued operations | $ | | $ | (304,576 | ) | $ | 313,979 | $ | (1,141,141 | ) |
In December 2005, the Company sold Ovonic Battery's metal hydride materials manufacturing business to Great Western Technologies Inc. (GWTI) for installment payments totaling $906,000, with an initial payment of $453,000; a second payment of $271,800 to be made no later than December 12, 2006; and a third payment of $181,200 (which has been discounted to $167,087) to be made no later than December 12, 2007. The Company recorded a gain on this sale of approximately $740,000 in the nine months ended March 31, 2006. In addition, GWTI assumed the lease obligations for two of Ovonic Battery's manufacturing plants. ECD is subleasing a portion of one of these facilities.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from those estimates.
Reclassifications
Certain prior year amounts have been reclassified to conform with fiscal year 2006 presentation.
9
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
Short-Term Investments
The Company has evaluated its investment policies consistent with SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities, and determined that all of its investment securities are classified as available-for-sale. Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in Stockholders Equity under the caption Accumulated other comprehensive income. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other than temporary on available-for-sale securities are included in other nonoperating income (expense). The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income. Short-term investments consist of corporate notes and certificates of deposit which mature 91 days or more from date of acquisition.
The following schedule summarizes the contractual maturities and unrealized gains and losses on the Company's short-term investments (in thousands):
Gross Unrealized | Estimated | |||||||||||
Cost | Gains | (Losses) | Fair Value | |||||||||
Due within one year or less at March 31, 2006 | ||||||||||||
Corporate Notes | $ | 73,794 | $ | | $ | | $ | 73,794 | ||||
Certificates of Deposit | 31,327 | $ | | (11 | ) | 31,316 | ||||||
$ | 105,121 | $ | | $ | (11 | ) | $ | 105,110 | ||||
Due within one year or less at June 30, 2005 | ||||||||||||
Corporate Notes | $ | 11,841 | $ | | $ | | $ | 11,841 |
Capitalized Interest
Interest on debt is capitalized during active construction periods of equipment. During the three and nine months ended March 31, 2006, the Company incurred total interest costs of $227,000 and $679,000, of which $227,000 and $482,000, respectively, were capitalized as part of the new solar cell manufacturing equipment currently under construction.
Overhead and Operating, General and Administrative Allocations
The Company allocates overhead and operating, general and administrative expenses to product development and research expenses and to cost of revenues from product development agreements based on a percentage of direct labor costs. For cost of revenues from product development agreements, this allocation is limited to the amount of revenues, after direct expenses, under the applicable agreements. Overhead is allocated to cost of product sales through the application of overhead to inventory costs.
10
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
The following is a summary of the gross operating, general and administrative expenses and the aforementioned allocations:
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Gross Expenses | $ | 9,744,000 | $ | 8,478,000 | $ | 23,591,000 | $ | 21,095,000 | ||||
Less | ||||||||||||
allocations to product development and research | (3,761,000 | ) | (2,369,000 | ) | (10,542,000 | ) | (7,720,000 | ) | ||||
allocations to cost of revenues from product | ||||||||||||
development agreements | (336,000 | ) | (564,000 | ) | (861,000 | ) | (2,020,000 | ) | ||||
Remaining Expenses | $ | 5,647,000 | $ | 5,545,000 | $ | 12,188,000 | $ | 11,355,000 |
Stock-Based Compensation
As of March 31, 2006, ECD had established a number of stock option plans as discussed in Note L. Prior to fiscal 2006, ECD applied the intrinsic value method as outlined in Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," ("APB No. 25") and related interpretations in accounting for stock options granted under these programs. Under the intrinsic value method, no compensation expense was recognized if the exercise price of ECD's employee stock options equaled the market price of the underlying stock on the date of the grant. Accordingly, no compensation cost was recognized in the accompanying consolidated statements of operations prior to fiscal year 2006 on stock options granted to employees, since all options granted under ECD's stock option plans had an exercise price equal to the market value of the underlying common stock on the date of grant.
Effective July 1, 2005, ECD adopted SFAS No. 123(R), "Share-Based Payment" ("SFAS No. 123(R)"). This statement replaces SFAS No. 123, "Accounting for Stock-Based Compensation" ("SFAS No. 123") and supersedes APB No. 25. SFAS No. 123(R) requires that all stock-based compensation be recognized as an expense in the financial statements and that such cost be measured at the fair value of the grant. This statement was adopted using the modified prospective method of application, which requires us to recognize compensation expense on a prospective basis. Therefore, prior period financial statements have not been restated. Under this method, in addition to reflecting compensation expense for new share-based grants, expense is also recognized to reflect the remaining service period of grants that had been included in pro-forma disclosures in prior periods. SFAS No. 123(R) also requires that excess tax benefits (none for the Company due to tax losses) related to stock option exercises be reflected as financing cash inflows instead of operating cash inflows.
With the adoption of SFAS No. 123(R), ECD is required to record the fair value of stock-based compensation grants as an expense. In order to determine the fair value of stock options on the date of grant, ECD applies the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option life, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective
11
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
assumptions, typically based on factual data derived from public sources, the expected stock-price volatility and option life assumptions require a greater level of judgment which make them critical accounting estimates.
ECD uses an expected stock-price volatility assumption that is based on historical implied volatilities of the underlying stock which is obtained from public data sources.
With regard to the weighted-average option life assumption, ECD considers the exercise behavior of past grants and models the pattern of aggregate exercises. Patterns are determined on specific criteria of the aggregate pool of optionees.
In October 2005, the Financial Accounting Standards Board issued FASB Staff Position (FSP) No. FAS 123(R)-2, "Practical Accommodation to the Application of Grant Date as defined in FASB Statement No. 123(R)," to provide guidance on determining the grant date for a grant as defined in SFAS No. 123(R). This FSP stipulates that assuming all other criteria in the grant date definition are met, a mutual understanding of the key terms and conditions of a grant to an individual employee is presumed to exist upon the grant's approval in accordance with the relevant corporate governance requirements, provided that the key terms and conditions of a grant (a) cannot be negotiated by the recipient with the employer because the grant is a unilateral grant, and (b) are expected to be communicated to an individual recipient within a relatively short time period from the date of approval. ECD has applied the principles set forth in this FSP upon its adoption of SFAS No. 123(R).
Basic and Diluted Net Income (Loss) Per Share
Basic net income (loss) per common share is computed by dividing the net income (loss) by the weighted average number of common shares outstanding. ECD uses the treasury stock method to calculate diluted earnings per share. Potential dilution exists from stock options and warrants. Weighted average number of shares outstanding and basic and diluted net income (loss) per share for the three months and nine months ended March 31, 2006 and 2005 are computed as follows:
12
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Weighted average number of shares outstanding: | ||||||||||||
for basic net income (loss) per share | 32,597,752 | 28,688,992 | 30,330,510 | 26,438,055 | ||||||||
for diluted net income (loss) per share | 32,597,752 | 28,688,992 | 30,330,510 | 27,537,033 | ||||||||
Net income (loss) from continuing operations | $ | (5,626,035 | ) | $ | (10,945,412 | ) | $ | (18,141,255 | ) | $ | 56,110,091 | |
Gain (loss) on discontinued operations | | (304,576 | ) | 313,979 | (1,141,141 | ) | ||||||
Extraordinary item | | | | 2,266,326 | ||||||||
Net income (loss) | $ | (5,626,035 | ) | $ | (11,249,988 | ) | $ | (17,827,276 | ) | $ | 57,235,276 | |
Basic net income (loss) per share | ||||||||||||
Continuing operations | $ | (.17 | ) | $ | (.38 | ) | $ | (.60 | ) | $ | 2.12 | |
Discontinued operations | | (.01 | ) | .01 | (.04 | ) | ||||||
Extraordinary item | | | | .08 | ||||||||
Basic net income (loss) per share | $ | (.17 | ) | $ | (.39 | ) | $ | (.59 | ) | $ | 2.16 | |
Diluted net income (loss) per share | ||||||||||||
Continuing operations | $ | (.17 | ) | $ | (.38 | ) | $ | (.60 | ) | $ | 2.04 | |
Discontinued operations | | (.01 | ) | .01 | (.04 | ) | ||||||
Extraordinary item | | | | .08 | ||||||||
Diluted net income (loss) per share | $ | (.17 | ) | $ | (.39 | ) | $ | (.59 | ) | $ | 2.08 |
Additional weighted average shares outstanding for the 2006 periods are due to the public offering of 7,000,000 shares in March 2006 and the exercise of warrants to purchase 1,946,162 shares of Common Stock in April/May 2005.
Due to the Companys net loss in the three months and nine months ending March 31, 2006, weighted average shares of potential dilutive securities of 2,075,889 and 2,253,473, respectively, were excluded from the calculations of diluted net loss per share, as inclusion of these securities would have been antidilutive to the net loss per share.
Due to the Company's net loss in the three months ending March 31, 2005, weighted average shares of potential dilutive securities of 1,559,894 were excluded from the calculations of diluted net loss per share, as inclusion of these securities would have been antidilutive to the net loss per share.
Additional securities of 330,600 for the three months ended March 31, 2005 and 668,656 for the nine months ended March 31, 2005 were excluded from the 2005 calculations of weighted average shares of potentially dilutive securities. Because of the relationship between the exercise prices and the average market price of ECDs Common Stock during these periods, these securities would have been antidilutive regardless of the Companys net income or loss.
13
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE A Summary of Accounting Policies (Continued)
Recent Pronouncements
In February 2006, the FASB issued SFAS No. 155, Accounting for Certain Hybrid Instruments. This statement allows financial instruments that have embedded derivatives to be accounted for as a whole (eliminating the need to bifurcate the derivative from its host) if the holder elects to account for the whole instrument on a fair value basis. This statement is effective for all financial instruments acquired or issued after the beginning of an entitys first fiscal year that begins after September 15, 2006. The Company is in the process of reviewing this statement for the future effect on the Companys consolidated financial position and results of operations.
In February 2006, the FASB issued FASB Staff Position No. FAS 123(R)-4, Classification of Options and Similar Instruments Issued as Employee Compensation That Allow for Cash Settlement upon the Occurrence of a Contingent Event. This FASB Staff Position (FSP) addresses the classification of options and similar instruments issued as employee compensation that allow for cash settlement upon the occurrence of a contingent event.
The guidance in this FSP is applied upon initial adoption of Statement 123(R). An entity that adopted Statement 123(R) prior to the issuance of this FSP shall apply the guidance in this FSP in the first reporting period beginning after the date the FSP is posted to the FASB website. If in applying Statement 123(R) an entity treated options or similar instruments that allow for cash settlement upon the occurrence of a contingent event in a manner consistent with the guidance in this FSP, then that entity would not be required to retrospectively apply the guidance in this FSP to prior periods. However, if in applying Statement 123(R) an entity treated options or similar instruments that allow for cash settlement upon the occurrence of a contingent event in a manner inconsistent with the guidance in this FSP, then that entity would be required to retrospectively apply the guidance in this FSP to prior periods. Early application of this guidance is permitted in periods for which financial statements have not yet been issued. It is anticipated that the adoption of this standard will not have a material effect on the Companys financial position or results of operations.
NOTE B Settlement Agreement
In July 2004, ECD announced that it and Cobasys had entered into a settlement agreement with Matsushita Electric Industrial Co. (MEI), Panasonic EV Energy Co., Ltd. (PEVE), and Toyota Motor Corporation with respect to patent infringement disputes and counterclaims involving nickel metal hydride (NiMH) batteries before the International Chamber of Commerce, International Court of Arbitration. Under the terms of the settlement, no party admitted any liability.
As part of the settlement, ECD and its subsidiary, Ovonic Battery, received a $10 million license fee from MEI and PEVE. This fee was recorded as a deferred patent license fee in July 2004 and is being amortized to income over 10.5 years. The Company recognized $238,000 and $714,000 as revenues from license and other agreements in both the three months and nine months ended March 31, 2006 and 2005, respectively, in connection with the amortization
14
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE B Settlement Agreement (Continued)
of this fee. In addition, Cobasys received a $20 million license fee from MEI, PEVE and Toyota, of which $4 million was placed in escrow for a next-generation NiMH battery development project plan. Upon receipt of the license fee, Cobasys, in September 2004, made an $8 million distribution each to Ovonic Battery and Chevron representing a partial reimbursement of legal expenses. The Company recorded this $8 million as a distribution from joint venture in the nine months ended March 31, 2005.
NOTE C Accounts Receivable
March 31, 2006 | June 30, 2005 | |||||
Long-term contracts accounted for under percentage- | ||||||
of-completion accounting | ||||||
Amounts billed to customers | ||||||
Commercial customers | $ | 21,118 | $ | | ||
Long-term contracts not accounted for under | ||||||
percentage-of-completion accounting | ||||||
Amounts unbilled principally on U.S. Government | ||||||
contracts | 959,734 | 804,065 | ||||
Amounts billed principally U.S. Government | 725,828 | 1,369,633 | ||||
Sub-total | 1,685,562 | 2,173,698 | ||||
Amounts unbilled for other than long-term contracts | ||||||
Commercial customers | 3,393,338 | 3,432,048 | ||||
Amounts billed for other than long-term contracts | ||||||
Commercial customers | 19,093,136 | 14,338,729 | ||||
Allowance for uncollectible accounts | (510,000 | ) | (412,000 | ) | ||
TOTAL | $ | 23,683,154 | $ | 19,532,475 |
15
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE D Inventories
Inventories of raw materials, work in process and finished goods for the manufacture of solar cells and nickel hydroxide are valued at the lower of cost (first in, first out) or market. Cost elements included in inventory are materials, direct labor and manufacturing overhead.
Inventories (substantially all for United Solar Ovonic) are as follows:
March 31, 2006 | June 30, 2005 | |||||
Finished products | $ | 1,774,235 | $ | 5,104,043 | ||
Work in process | 3,862,261 | 3,150,529 | ||||
Raw materials | 15,553,568 | 9,812,304 | ||||
$ | 21,190,064 | $ | 18,066,876 |
NOTE E Joint Ventures and Investments
Joint Ventures
Cobasys
In July 2001, Ovonic Battery and Chevron formed a strategic alliance (Cobasys LLC). Chevron invested $160,000,000 to match the Company's technological contribution in the venture. Cobasys is owned 50% by Ovonic Battery and 50% by Chevron.
In December 2004, as part of its focus on its core businesses, ECD and Ovonic Battery entered into a series of agreements with Chevron and Cobasys to expand the scope of licenses granted to Cobasys at the time of the restructuring of the joint venture in July 2001. In consideration of the expanded licenses, ECD and Ovonic Battery received an option to purchase 4,376,633 shares, exercisable at $4.55 per share, of ECD Common Stock then owned by Chevron. The transaction increased Ovonic Battery's revenue and decreased additional paid-in capital in the year ended June 30, 2005 by $79,532,000 based upon the value of this option using the Black-Scholes valuation model.
In July 2004, ECD and Cobasys entered into a settlement agreement with MEI, PEVE, and Toyota with respect to patent infringement disputes and counterclaims involving NiMH batteries before the International Chamber of Commerce, International Court of Arbitration. Under the terms of the settlement, no party admitted any liability. (See Note B for additional information on this settlement.)
16
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE E Joint Ventures and Investments (Continued)
The Company recorded revenues from Cobasys of $178,000 and $815,000 for the three months and nine months ending March 31, 2006, respectively, and $461,000 and $1,528,000 for the three months and nine months ended March 31, 2005, respectively, for services performed on behalf of Cobasys.
The following sets forth certain financial data regarding Cobasys that are derived from its financial statements:
COBASYS LLC AND SUBSIDIARY
(A Development Stage Enterprise)
STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Revenue | ||||||||||||
Product and prototype revenues | $ | 358,390 | $ | 295,140 | $ | 694,053 | $ | 714,180 | ||||
Other revenues | 587,572 | 760,000 | 2,084,597 | 2,069,946 | ||||||||
Total Revenue | 945,962 | 1,055,140 | 2,778,650 | 2,784,126 | ||||||||
Expenses | ||||||||||||
Operating expenses | 11,530,247 | 10,854,882 | 32,478,099 | 26,643,100 | ||||||||
Loss (gain) on asset impairment | ||||||||||||
and disposal | (26,510 | ) | 1,951,432 | 197,621 | 1,951,432 | |||||||
Interest expense | 1,041,543 | | 2,281,722 | | ||||||||
Total Expenses | 12,545,280 | 12,806,314 | 34,957,442 | 28,594,532 | ||||||||
Net Loss | $ | (11,599,318 | ) | $ | (11,751,174 | ) | $ | (32,178,792 | ) | $ | (25,810,406 | ) |
17
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE E Joint Ventures and Investments (Continued)
COBASYS LLC AND SUBSIDIARY
(A Development Stage Enterprise)
BALANCE SHEETS
March 31, 2006 | June 30, 2005 | |||||||||||
(Unaudited) | (Audited) | |||||||||||
Assets | ||||||||||||
Current Assets: | ||||||||||||
Cash and cash equivalents (of which $1,050,604 is | ||||||||||||
restricted as of June 30, 2005) | $ | 1,591,395 | $ | 2,375,677 | ||||||||
Investment securities (restricted) | | 1,994,000 | ||||||||||
Accounts receivable (net of allowance of $2,750 | ||||||||||||
and $10,577 as of March 31, 2006 and | ||||||||||||
June 30, 2005, respectively) | 1,732,097 | 1,516,034 | ||||||||||
Inventories, net | 4,702,735 | 3,540,791 | ||||||||||
Other current assets | 568,091 | 249,729 | ||||||||||
Total Current Assets | 8,594,318 | 9,676,231 | ||||||||||
Net Property, Plant and Equipment | 40,599,291 | 35,902,091 | ||||||||||
Other Assets | 760,516 | 1,133,011 | ||||||||||
Total Assets | $ | 49,954,125 | $ | 46,711,333 | ||||||||
Liabilities and Members' Capital | ||||||||||||
Other current liabilities | $ | 4,464,738 | $ | 5,855,949 | ||||||||
Deferred revenue - current portion | 1,975,487 | 2,150,000 | ||||||||||
Total Current Liabilities | 6,440,225 | 8,005,949 | ||||||||||
Deferred revenue - noncurrent | 14,860,480 | 16,295,219 | ||||||||||
Redeemable preferred interest related party | 57,724,667 | 20,135,095 | ||||||||||
Other noncurrent liabilities | 1,891,201 | 1,058,726 | ||||||||||
Total Liabilities | 80,916,573 | 45,494,989 | ||||||||||
Members' Interest | (30,962,448 | ) | 1,216,344 | |||||||||
Total Liabilities and Members' Interest | $ | 49,954,125 | $ | 46,711,333 |
Ovonyx
As of March 31, 2006, ECD owned 39.5% of Ovonyx, Mr. Tyler Lowrey and his colleague owned 39.5% of Ovonyx, and Intel Capital and other investors owned the remainder of the shares outstanding without giving effect to the exercise of outstanding stock options. ECD has principally contributed intellectual property and licenses for its interest in Ovonyx.
In October 2002, ECD, through a newly formed company, Ovonic Cognitive Computer, Inc., which is owned 95% by ECD and 5% by Ovonyx, made a capital contribution of $1,000,000 in Ovonyx in exchange for technology previously contributed by ECD to Ovonyx and an
18
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE E Joint Ventures and Investments (Continued)
exclusive, royalty-bearing license, which requires annual minimum royalty payments in order to maintain its exclusivity. ECD made a $50,000 minimum royalty payment in November 2003, a $100,000 payment in December 2004, and $150,000 in December 2005. ECD recorded its $1,300,000 investment in Ovonyx and accounts for this investment on the equity method and recognized its proportionate share ($105,000 and $150,000, respectively, in the three and nine months ended March 31, 2006 and $100,000 in the nine months ended March 31, 2005) of Ovonyx losses to the extent of its $1,300,000 investment.
ECD recorded revenues from Ovonyx of $121,000 and $376,000, respectively, for the three months and nine months ended March 31, 2006 and $52,000 and $177,000, respectively, for the three months and nine months ended March 31, 2005, representing services provided to Ovonyx.
Ovonic Hydrogen Systems
In October 2000, ECD and Chevron formed Texaco Ovonic Hydrogen Systems. Chevron funded the initial product and market development for this joint venture, the primary use of which was to fund a contract from Texaco Ovonic Hydrogen Systems to ECD to further develop the Ovonic hydrogen storage technology. In December 2004, Chevron transferred to ECD its interest in Texaco Ovonic Hydrogen Systems (renamed Ovonic Hydrogen Systems LLC by ECD). In accordance with SFAS 141, "Business Combinations," the Company wrote down the assets and liabilities of Ovonic Hydrogen Systems to zero in December 2004. ECD received $4,675,000 from Chevron for payment of restructuring fees. The $4,675,000 received from Chevron was $2,266,000 (net of tax) in excess of restructuring costs.
Since December 2, 2004, Ovonic Hydrogen Systems has been wholly owned by ECD. It is funded by ECD at a reduced level and is included in the Company's consolidated financial statements. Ovonic Hydrogen Systems is focusing on continuing to commercialize compact portable hydrogen storage canisters that have current and near-term market applications while continuing to develop and commercialize ECD's proprietary reversible solid metal hydride-based low-pressure hydrogen storage system for longer-term stationary, transportation and infrastructure applications.
During the nine months ended March 31, 2005, the Company recorded revenues of $4,089,000 for services provided to this joint venture, primarily for market development and advanced product development work.
Investments in Rare Earth Ovonic
During the year ended June 30, 2000, ECD and Ovonic Battery formed three joint ventures for the manufacturing and licensing of advanced NiMH battery technology, alloy powders and certain battery applications. ECD and Ovonic Battery initially contributed technology for their 19% interest in each of these joint ventures. In February 2002, ECD and Ovonic Battery jointly made a proportionate $1,710,000 cash investment in the Rare Earth Ovonic joint ventures and maintained their 19% interest in these entities. All of these joint ventures are being accounted for using the cost method of accounting.
19
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE E Joint Ventures and Investments (Continued)
Ovonic Battery has three contracts totaling $63,600,000 for supplying equipment and technology to its Rare Earth Ovonic joint ventures. As of March 31, 2006, Ovonic Battery received payments totaling $59,484,000 under the three contracts. In December 2004, the Company reviewed its estimates to complete the equipment under the Rare Earth Ovonic contracts. As a result of this review and the changes in estimates, the Company reduced its estimated margin from 12% to 8%. This resulted in a reduction in the cumulative revenue for these contracts at March 31, 2005 of approximately $2,668,000. The Company reviewed its estimates at March 31, 2006 and no additional adjustments were made.
The Company recorded revenues related to the above equipment contracts from Rare Earth Ovonic of $62,000 and $759,000 for the three months and nine months ended March 31, 2006 and $498,000 and a negative $1,100,000 for the three months and nine months ended March 31, 2005, respectively. At December 31, 2004, the Company reviewed its revenues and cost estimates for its Rare Earth Ovonic joint ventures in connection with its investment ($1,710,000) in Rare Earth Ovonic. Based upon these estimates, the Company took an impairment charge of $1,710,000 as of December 31, 2004.
As of March 31, 2006, the Company has recorded revenues equal to cash it has received under the contracts. Additional amounts are due the Company under the contracts but all amounts have been reserved as uncollectible and no revenues will be recorded until such time as cash is received.
NOTE F Liabilities and Line of Credit
Warranty Liability
The Company estimates the liability for product warranty costs based upon its past experience and best estimate of future warranty claims. The following is a summary of the changes in the product warranty liability during the nine months ended March 31, 2006 and 2005:
Nine Months Ended March 31, | ||||||
2006 | 2005 | |||||
Liability beginning of the period | $ | 1,635,532 | $ | 1,945,934 | ||
Amounts accrued for as warranty costs | 182,227 | (203,228 | )* | |||
Warranty claims | (101,121 | ) | (172,708 | ) | ||
Liability at March 31 | $ | 1,716,638 | $ | 1,569,998 |
* During the nine months ended March 31, 2005, United Solar Ovonic LLC revised its warranty liability, based upon
its recent experience, and recorded a reduction in this liability.
20
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE F Liabilities and Line of Credit (Continued)
Warranty liability is recorded at the time that the product is sold (for sales of photovoltaic products) or at the time that revenue is recognized (for machine-building and equipment sales).
Government Contract Reserve
The Companys contracts with the U.S. Government and its agencies are subject to audits by the Defense Contract Audit Agency (DCAA). DCAA has audited the Companys indirect rates, including its methodology of computing these rates, for the years through June 30, 2003. In its reports, DCAA has questioned the allowability of and the allocability of certain costs as well as the Companys methodology for allocating independent research and development to its indirect cost pools. In addition, DCAA has stated that there could be penalties imposed. The Company is in the process of discussing each of these items in detail with the Department of Energy. Management believes that some of these DCAA assertions are without merit. The Company has recorded a reserve of $2,626,000 and $2,294,000 at March 31, 2006 and June 30, 2005, respectively, related to these issues.
Business Loan Agreement
The Company has a business loan agreement with LaSalle Bank in the amount of $4,000,000. This business loan agreement is used to provide a mechanism for the issuances of letters of credit and entering into foreign currency exchange transactions. The business loan agreement expires on August 31, 2006. This agreement contains certain covenants, including a minimum $20 million liquidity covenant. At March 31, 2006, the Company had outstanding letters of credit of $2,161,000 against the business loan agreement.
NOTE G Commitments
The Company, in the ordinary course of business, enters into purchase commitments for raw materials. The Company also enters into purchase commitments for capital equipment, including subcontracts for the purchase of components for the new solar cell manufacturing equipment. The Company's total obligations under purchase commitments at March 31, 2006, were $39,850,000 ($36,658,000 of which was due within one year and $3,192,000 thereafter). The increase in purchase commitments is primarily due to new purchase commitments for the new solar cell manufacturing equipment and for raw materials for United Solar Ovonic.
21
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE H Nonrefundable Advance Royalties
At March 31, 2006 and June 30, 2005, the Company deferred recognition of revenue relating to nonrefundable advance royalty payments, which consist of the following:
March 31, 2006 | June 30, 2005 | |||||||||||
Battery | $ | 435,902 | $ | 435,902 | ||||||||
Optical memory | 23,560 | 715,777 | ||||||||||
$ | 459,462 | $ | 1,151,679 |
Creditable royalties earned and recognized as revenue were:
March 31, | ||||||
2006 | 2005 | |||||
Three months ended | $ | 674,751 | $ | (2,190 | ) | |
Nine months ended | $ | 692,217 | $ | 1,830,302 |
Included in creditable royalties are $690,000, in the three months and nine months ended March 31, 2006, and $1,811,000, in the nine months ended March 31, 2005, related to advance royalty payments, made in prior years by licensees to the Company, associated with license agreements under which the licensees no longer have contractual obligations to make payments.
There are no obligations in connection with any of the advance royalty agreements which require the Company to incur any additional costs.
NOTE I Product Sales, Royalties, Revenues from Product Development Agreements and License and Other Agreements
The Company has product sales and business agreements with third parties and with related parties for which royalties and revenues are included in the consolidated statements of operations. Product sales include photovoltaic products, revenues related to machine-building and equipment sales contracts and nickel hydroxide. Revenues related to machine-building and equipment sales contracts are recognized on the percentage-of-completion method of accounting using the costs incurred to date as a percentage of the total estimated costs. All other product sales are recognized when the product is delivered to the customer.
A summary of all of the Companys revenues follows.
22
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE I Product Sales, Royalties, Revenues from Product Development Agreements and License and Other Agreements (Continued)
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Product sales | ||||||||||||
Photovoltaics | $ | 21,074,725 | $ | 12,495,412 | $ | 60,034,237 | $ | 36,706,755 | ||||
Machine building and equipment sales | 62,095 | 498,244 | 779,714 | (1,099,791 | )* | |||||||
Nickel hydroxide | 226,733 | 455,997 | 1,491,155 | 709,838 | ||||||||
Other | 37,826 | | 43,886 | | ||||||||
Total product sales | $ | 21,401,379 | $ | 13,449,653 | $ | 62,348,992 | $ | 36,316,802 | ||||
Royalties | ||||||||||||
Battery technology | ||||||||||||
Transportation | $ | 308,674 | $ | 228,440 | $ | 950,987 | $ | 734,716 | ||||
Consumer | 660,793 | ** | 383,883 | 1,433,143 | ** | 2,226,062 | *** | |||||
Optical memory | 730,231 | *** | 54,994 | 825,663 | *** | 781,068 | *** | |||||
Ovonic Unified Memory | 4,139 | 2,811 | 8,290 | 4,496 | ||||||||
Total royalties | $ | 1,703,837 | $ | 670,128 | $ | 3,218,083 | $ | 3,746,342 | ||||
Revenues from product development agreements | ||||||||||||
Photovoltaics | $ | 2,123,754 | $ | 2,145,399 | $ | 4,397,915 | $ | 6,771,982 | ||||
Battery technology | 25,153 | (20,751 | ) | 41,878 | (20,603 | ) | ||||||
Optical memory | 237,201 | 283,337 | 596,081 | 768,922 | ||||||||
Solid hydrogen storage systems | 212,222 | 143,695 | 454,214 | 291,668 | ||||||||
Manufacturing technology for OLEDs | 398,189 | 349,632 | 995,384 | 1,261,213 | ||||||||
Fuel cell technology | 149,687 | | 284,667 | | ||||||||
3,146,206 | 2,901,312 | 6,770,139 | 9,073,182 | |||||||||
Revenues from product development agreements - related parties | ||||||||||||
Battery technology | 120,936 | 460,586 | 677,508 | 1,527,853 | ||||||||
Solid hydrogen storage systems | | | | 4,088,924 | ||||||||
120,936 | 460,586 | 677,508 | 5,616,777 | |||||||||
Total revenues from product development agreements | $ | 3,267,142 | $ | 3,361,898 | $ | 7,447,647 | $ | 14,689,959 | ||||
License and other agreements | ||||||||||||
Battery technology | $ | 288,080 | $ | 238,095 | $ | 784,270 | $ | 80,246,285 |
* |
Reflects adjustment in percentage of completion revenues as of December 31, 2004. (See Note E.) |
** |
Includes $275,000 in the three and nine months ended March 31, 2006 for past royalties from a consumer licensee. |
*** |
Includes $690,000 in the three months and nine months ended March 31, 2006 and $686,000 in the nine months ended March 31, 2005 for optical memory and $1,125,000 in the nine months ended March 31, 2005 for consumer battery related to advance royalty payments, made in prior years by licensees associated with license agreements under which the licensees no longer have contractual obligations to make payments (see Note H). |
23
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE I Product Sales, Royalties, Revenues from Product Development Agreements and License and Other Agreements (Continued)
The following table presents revenues by country based on the location of the customer:
Three Months Ended March 31, |
Nine Months Ended March 31, |
|||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
United States | $ | 15,239,415 | $ | 9,683,990 | $ | 35,412,165 | $ | 114,010,132 | ||||
Germany | 7,063,154 | 4,958,057 | 22,910,137 | 12,689,054 | ||||||||
Japan | 1,865,326 | 813,914 | 3,615,965 | 4,202,148 | ||||||||
China | 470,003 | 1,059,676 | 2,739,329 | (130,549 | )* | |||||||
Other Countries | 2,319,410 | 1,379,966 | 9,812,046 | 4,891,051 | ||||||||
$ | 26,957,308 | $ | 17,895,603 | $ | 74,489,642 | $ | 135,661,836 |
* |
See Note E. |
24
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE J Business Segments
The Company has three business segments: United Solar Ovonic, Ovonic Battery and the parent company, ECD. United Solar Ovonic is involved in manufacturing and selling photovoltaic products. Ovonic Battery is involved in developing and licensing Ovonic NiMH consumer battery technology and manufacturing of nickel hydroxide materials. ECD is involved in developing microelectronics, fuel cells, hydrogen storage, catalysis, photovoltaics technologies and machine building. Some general corporate expenses have been allocated to Ovonic Battery.
The Company's operations by business segments were as follows:
Financial Data by Business Segment
(in thousands)
United Solar Ovonic |
ECD | Ovonic Battery | Consolidating Entries |
Consolidated | |||||||||||
Revenues* | |||||||||||||||
Three months ended | |||||||||||||||
March 31, 2006 | $ | 23,059 | $ | 14,311 | $ | 1,811 | $ | (12,224 | ) | $ | 26,957 | ||||
March 31, 2005 | 14,425 | 1,748 | 2,308 | (585 | ) | 17,896 | |||||||||
Nine months ended | |||||||||||||||
March 31, 2006 | $ | 64,069 | $ | 41,018 | $ | 6,358 | $ | (36,955 | ) | $ | 74,490 | ||||
March 31, 2005 | 43,008 | 9,791 | 84,457 | (1,594 | ) | 135,662 | |||||||||
Operating Income (Loss)* | |||||||||||||||
Three months ended | |||||||||||||||
March 31, 2006 | $ | 2,552 | $ | (9,193 | ) | $ | (891 | ) | $ | 78 | $ | (7,454 | ) | ||
March 31, 2005 | (1,052 | ) | (9,164 | ) | (1,095 | ) | 25 | (11,286 | ) | ||||||
Nine months ended | |||||||||||||||
March 31, 2006 | $ | 5,989 | $ | (23,391 | ) | $ | (3,659 | ) | $ | (240 | ) | $ | (21,301 | ) | |
March 31, 2005 | (3,590 | ) | (18,966 | ) | 72,511 | 662 | 50,617 | ||||||||
Interest Income** | |||||||||||||||
Three months ended | |||||||||||||||
March 31, 2006 | $ | 21 | $ | 2,904 | $ | 2 | $ | (994 | ) | $ | 1,933 | ||||
March 31, 2005 | 8 | 1,104 | | (703 | ) | 409 | |||||||||
Nine months ended | |||||||||||||||
March 31, 2006 | $ | 52 | $ | 6,080 | $ | 2 | $ | (2,604 | ) | $ | 3,530 | ||||
March 31, 2005 | 21 | 2,664 | | (2,091 | ) | 594 |
25
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE J Business Segments (Continued)
United Solar Ovonic |
ECD | Ovonic Battery | Consolidating Entries |
Consolidated | |||||||||||||
Interest Expense** | |||||||||||||||||
Three months ended | |||||||||||||||||
March 31, 2006 | $ | 995 | $ | | $ | | $ | (995 | ) | $ | | ||||||
March 31, 2005 | 935 | | | (865 | ) | 70 | |||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | 2,802 | $ | | $ | | $ | (2,605 | ) | $ | 197 | ||||||
March 31, 2005 | 2,794 | | | (2,253 | ) | 541 | |||||||||||
Equity in Net Loss of Investees | |||||||||||||||||
Under Equity Method | |||||||||||||||||
Three months ended | |||||||||||||||||
March 31, 2006 | $ | | $ | (105 | ) | $ | | $ | | $ | (105 | ) | |||||
March 31, 2005 | | | | | | ||||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | | $ | (150 | ) | $ | | $ | | $ | (150 | ) | |||||
March 31, 2005 | | (100 | ) | | | (100 | ) | ||||||||||
Depreciation Expense | |||||||||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | 3,991 | $ | 1,325 | $ | 269 | $ | | $ | 5,585 | |||||||
March 31, 2005 | 4,033 | 1,660 | 377 | | 6,070 | ||||||||||||
Capital Expenditures | |||||||||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | 38,715 | $ | 1,567 | $ | 451 | $ | (286 | ) | $ | 40,447 | ||||||
March 31, 2005 | 865 | 98 | 81 | | 1,044 | ||||||||||||
Investments in and Advances | |||||||||||||||||
to Equity Method Investees | |||||||||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | | $ | | $ | | $ | | $ | | |||||||
March 31, 2005 | | | | | | ||||||||||||
Identifiable Assets | |||||||||||||||||
Nine months ended | |||||||||||||||||
March 31, 2006 | $ | 132,710 | $ | 551,182 | $ | 4,818 | $ | (156,428 | ) | $ | 532,282 | ||||||
March 31, 2005 | 80,784 | 218,799 | 4,687 | (109,547 | ) | 194,723 |
* | Excludes discontinued operations (Ovonic Battery). |
** | Excludes intercompany interest between ECD and Ovonic Battery. |
26
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE K Other Comprehensive Income (Loss)
The Company's total comprehensive income (loss) was as follows:
Three Months Ended March 31, |
Nine Months Ended March 31, | |||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||
Net Income (Loss) | $ | (5,626,035 | ) | $ | (11,249,988 | ) | $ | (17,827,276 | ) | $ | 57,235,276 | |
OTHER COMPREHENSIVE | ||||||||||||
INCOME (LOSS) (net of taxes): | ||||||||||||
Net unrealized losses on investments | (10,609 | ) | | (10,609 | ) | | ||||||
Foreign currency translation adjustments | (89,763 | ) | 45,097 | (259,557 | ) | 101,679 | ||||||
COMPREHENSIVE INCOME (LOSS) | $ | (5,726,407 | ) | $ | (11,204,891 | ) | $ | (18,097,442 | ) | $ | 57,336,955 |
There was an unrealized holding loss on investments of $10,609 arising during the three months and nine months ended March 31, 2006. There were no reclassification adjustments for gains realized in net income for the three months and nine months ended March 31, 2006 and 2005.
The accumulated income (expense) balances of currency translation adjustments, net of taxes, were $(47,971) and $211,586 at March 31, 2006 and June 30, 2005, respectively. For the three months ended March 31, 2006 and 2005, the effect from foreign currency transactions was a loss of $1,910 and $229,712, respectively. For the nine months ended March 31, 2006 and 2005, the effect from foreign currency transactions was a loss of $67,968 and a gain of $44,708, respectively.
27
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE L Capital Stock
On September 30, 2005, in accordance with the applicable agreements, 219,913 shares of Class A Convertible Stock and 430,000 shares of Class B Convertible Stock were converted into Common Stock on a share-for-share basis.
ECD has common stock reserved for issuance as follows:
Number of Shares | ||||||
March 31, 2006 | June 30, 2005 | |||||
Conversion of Class A Convertible Common Stock | | 219,913 | ||||
Conversion of Class B Convertible Common Stock | | 430,000 | ||||
Stock options | 3,269,089 | 4,410,476 | ||||
2006 Equity Offering (Over-allotment option)* | 1,050,000 | | ||||
Warrants | 400,000 | 1,790,892 | ||||
Convertible Investment Certificates | 5,210 | 5,210 | ||||
TOTAL RESERVED SHARES | 4,724,299 | 6,856,491 |
* |
The 1,050,000 shares were exercised on April 4, 2006 by the underwriters of the March 2006 public offering (see pages 32 and 46 for more information on the public offering). |
ECD has two shareholder-approved plans: the 1995 Non-Qualified Stock Option Plan pursuant to which 2,000,000 shares were reserved for grant and the 2000 Non-Qualified Stock Option Plan pursuant to which 3,000,000 shares were reserved for grant. The plans authorize the granting of stock options at such exercise prices and to such employees, consultants and other persons as the Compensation Committee appointed by the Board of Directors (the Compensation Committee) shall determine. The 1995 Stock Option Plan provides that no option shall be granted after January 26, 2005. The 2000 Stock Option Plan provides that no option shall be granted after October 25, 2010.
The exercise period for stock options generally may not exceed 10 years from the date of grant. Stock option grants to individuals generally become exercisable with 40% of the shares vesting one year after the date of grant and 20% after each of the second, third and fourth years of grant.
In September 1993, ECDs Compensation Committee authorized ECD to cancel stock options to purchase 94,367 and 49,630 shares of Common Stock held by Stanford R. Ovshinsky and Dr. Iris M. Ovshinsky, respectively, which previously had been granted under ECDs Amended and Restated Stock Option Plan and to grant stock options to purchase 150,000 (391,294 as of March 31, 2006) and 100,000 (260,865 as of March 31, 2006) shares of Common Stock to Mr. and Dr. Ovshinsky, respectively, which were subsequently granted to them pursuant to Stock Option agreements dated November 1993 (the Agreements). The weighted average exercise price of the outstanding stock options is $17.70 per share at March 31, 2006.
28
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE L Capital Stock (Continued)
A summary of the transactions during the three months and nine months ended March 31, 2006 with respect to the above Agreements follows:
(Unaudited) | Shares | Weighted- Average Exercise Price |
Aggregate Intrinsic Value(1) (in millions) |
Weighted- Average Contractual Life Remaining in Years | ||||||||||
Outstanding at June 30, 2005 | 870,731 | $ 14.99 | ||||||||||||
Granted | | | ||||||||||||
Exercised | | | ||||||||||||
Expired | | | ||||||||||||
Forfeited | | | ||||||||||||
Outstanding at December 31, 2005 | 870,731 | $ 14.99 | $ 22.0 | (2) | ||||||||||
Granted | | | ||||||||||||
Exercised | (218,572) | $ 7.01 | $ 9.9 | |||||||||||
Expired | | | ||||||||||||
Forfeited | | | ||||||||||||
Outstanding at March 31, 2006 | 652,159 | $ 17.70 | $ 20.6 | (2) | ||||||||||
Exercisable at March 31, 2006 | 652,159 | $ 17.70 | $ 20.6 | (2) |
|
(1) |
The intrinsic value of a stock option is the amount by which the current market value of the underlying stock exceeds the exercise price of the option. |
|
(2) |
Twelve months after termination of employment other than voluntary termination. |
In June 2005, the Agreements were amended by deleting the antidilution protection adjustment provision. No further options will be granted to Mr. and Dr. Ovshinsky under the Agreements. In consideration of the approvals by Mr. and Dr. Ovshinsky to such amendment, ECDs Compensation Committee approved the grant of options to Mr. Ovshinsky (100,000 shares) and Dr. Ovshinsky (65,000 shares) under the 2000 Stock Option Plan.
On January 15, 1999, ECD entered into a Stock Option Agreement (the Agreement) with Robert C. Stempel that granted Mr. Stempel an option to purchase up to 300,000 shares of Common Stock at an exercise price of $10.688 per share, the fair market value of the Common Stock as of the date of the Agreement. The option, which is not subject to vesting requirements, may be exercised from time to time, in whole or in part, commencing as of the date of the Agreement and ending on the tenth anniversary of such date.
29
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE L Capital Stock (Continued)
A summary of the transactions during the three months and nine months ended March 31, 2006 with respect to the above Agreement follows:
(Unaudited) | Shares | Weighted- Average Exercise Price |
Aggregate Intrinsic Value(1) (in millions) |
Weighted- Average Contractual Life Remaining in Years | ||||||||||
Outstanding at June 30, 2005 | 300,000 | $ 10.688 | ||||||||||||
Granted | | | ||||||||||||
Exercised | | | ||||||||||||
Expired | | | ||||||||||||
Forfeited | | | ||||||||||||
Outstanding at December 31, 2005 | 300,000 | $ 10.688 | $ 9.00 | 3.04 | ||||||||||
Granted | | |||||||||||||
Exercised | | |||||||||||||
Expired | | |||||||||||||
Forfeited | | |||||||||||||
Outstanding at March 31, 2006 | 300,000 | $ 10.688 | $ 11.5 | 2.80 | ||||||||||
Exercisable at March 31, 2006 | 300,000 | $ 10.688 | $ 11.5 | 2.80 |
|
(1) |
The intrinsic value of a stock option is the amount by which the current market value of the underlying stock exceeds the exercise price of the option. |
Total net stock-based compensation expense is attributable to the granting of and the remaining requisite service periods of stock options previously granted. Compensation expense attributable to net stock-based compensation in the three months and nine months ended March 31, 2006 was $384,000 and $1,287,000, increasing both basic and diluted loss $.01 and $.04, respectively, per share. As of March 31, 2006, the total unrecognized compensation cost related to nonvested stock grants was $1.3 million and the related weighted-average period over which it is expected to be recognized is approximately 1.4 years.
Prior to the Company's adoption of SFAS No. 123(R), SFAS No. 123 required that the Company provide pro forma information regarding net earnings and net earnings per common share as if compensation cost for ECD's stock-based grants had been determined in accordance with the fair value method prescribed therein. ECD had previously adopted the disclosure portion of SFAS No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure," requiring quarterly SFAS No. 123 pro forma disclosure. The pro forma charge for compensation cost related to stock-based grants granted was recognized over the service period. For stock options, the service period represents the period of time between the date of grant and the date each option becomes exercisable without consideration of acceleration provisions.
30
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE L Capital Stock (Continued)
The following table illustrates the effect on net earnings per common share as if the fair value method had been applied to all outstanding grants for the three months and nine months ended March 31, 2005 (unaudited):
Three Months Ended March 31,2005 |
Nine Months Ended March 31,2005 |
|||||||||||
Net earnings, as reported | $ | (11,249,988 | ) | $ | 57,235,276 | |||||||
Deduct: | ||||||||||||
Total stock-based compensation expense determined under fair | ||||||||||||
value method for all grants | 412,803 | 1,413,743 | ||||||||||
Pro forma net earnings | $ | (11,662,791 | ) | $ | 55,821,533 | |||||||
Earnings per common share: | ||||||||||||
Basic as reported | $ | (.39 | ) | $ | 2.16 | |||||||
Basic pro forma | $ | (.41 | ) | $ | 2.11 | |||||||
Diluted as reported | $ | (.39 | ) | $ | 2.08 | |||||||
Diluted pro forma | $ | (.41 | ) | $ | 2.03 |
A summary of the transactions during the three months and nine months ended March 31, 2006 with respect to ECD's 1995 and 2000 Stock Option Plans follows:
(Unaudited) | Shares | Weighted- Average Exercise Price |
Aggregate Intrinsic Value(1) (in millions) |
Weighted- Average Contractual Life Remaining in Years | ||||||||||
Outstanding at June 30, 2005 | 2,268,635 | $ | 19.23 | |||||||||||
Granted | | | ||||||||||||
Exercised | (504,030 | ) | $ | 20.75 | ||||||||||
Expired | (54,800 | ) | $ | 15.94 | ||||||||||
Forfeited | (2,800 | ) | $ | 13.12 | ||||||||||
Outstanding at December 31, 2005 | 1,707,005 | $ | 18.90 | $ | 37.3 | 5.94 | ||||||||
Granted | | | ||||||||||||
Exercised | (364,335 | ) | $ | 18.67 | ||||||||||
Expired | | | ||||||||||||
Forfeited | (400 | ) | $ | 10.40 | ||||||||||
Outstanding at March 31, 2006 | 1,342,270 | $ | 18.96 | $ | 40.6 | 6.22 | ||||||||
Exercisable at March 31, 2006 | 969,775 | $ | 19.73 | $ | 28.6 | 5.44 |
|
(1) |
The intrinsic value of a stock option is the amount by which the current market value of the underlying stock exceeds the exercise price of the option. |
31
Table of Contents
ENERGY CONVERSION DEVICES, INC. and SUBSIDIARIES
Notes to Consolidated Financial Statements
NOTE L Capital Stock (Continued)
There were no stock option grants in the three months and nine months ended March 31, 2006 and 2005. The total intrinsic value of stock options exercised and the total fair value of stock options vested during the three months and nine months ended March 31, 2006 and 2005 were as follows:
|
Three Months Ended |
Nine Months Ended | ||
|
2006 |
2005 |
2006 |
2005 |
Total intrinsic value of stock options exercised |
$ 9,886,010 |
$ 328,566 |
$16,938,150 |
$ 7,585,597 |
Total fair value of stock options vested |
$ 92,397 |
$ 3,674,572 |
$ 1,454,782 |
$ 4,555,485 |
As of June 30, 2005, December 31, 2005 and March 31, 2006, there were 430,000 nonvested shares of restricted stock pursuant to a Restricted Stock Agreement dated January 19, 1999 and amended as of September 22, 2005 with a weighted average grant date fair value of approximately $4.6 million. The vesting schedule provides for quarterly vesting of 23,000 shares at the beginning of each quarter commencing July 1, 2006 through October 1, 2010 with 16,000 shares vesting on December 31, 2010.
In March 2006, ECD issued 7,000,000 new shares, including 383,072 shares sold by certain officers and directors, in connection with its stock offering and exercise of options with gross proceeds of approximately $324.2 million.
NOTE M Public Offering and Subsequent Event
In April 2006, the underwriters of ECDs public offering of 7,000,000 shares of ECD Common Stock (completed on March 7, 2006) exercised their over-allotment option in full and purchased an additional 1,050,000 shares. As a result, ECD received an additional $51.4 million in gross proceeds from the exercise of the over-allotment option, before underwriting discounts and commissions and expenses payable by it, bringing the total gross proceeds to ECD from the offering to approximately $375.6 million.
32
Table of Contents
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This Quarterly Report on Form 10-Q contains forward-looking statements about our financial condition, results of operations, plans, objectives, future performance and business. In addition, from time to time we and our representatives have made or may make forward-looking statements orally or in writing. The words "may," "will," "believes," "expects," "intends," "anticipates," "estimates," and similar expressions have been used in this Quarterly Report to identify forward-looking statements. These forward-looking statements speak only as of the date of this Quarterly Report. All subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are qualified in their entirety by the cautionary statements in this section. We are not obligated to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
We have based these forward-looking statements on our current expectations, estimates and projections with respect to future events and occurrences and managements beliefs and assumptions. Forward-looking statements are not guarantees of future performance and involve certain known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. The expected results reflected in our forward-looking statements are subject to various significant risks and uncertainties, including the following:
Risks Related to Our Business
|
|
We have a history of losses and our future profitability is uncertain. |
|
|
We expect that we will need to obtain additional significant financing to continue to operate our business, including significant capital expenditures to increase our production capacity, and financing may be unavailable or available only on disadvantageous terms. |
|
|
Our revenues and profits are dependent upon licensing arrangements and joint ventures, and our licensees and joint venture partners may be unwilling or unable to devote their financial resources and manufacturing and marketing capabilities to commercialize products based on our technologies. |
|
|
Additional research and development efforts will be required before certain products based on our technologies can be manufactured and sold commercially, and there can be no assurance that such efforts will be successful. |
|
|
It is uncertain that the market will accept our products once the technology has been developed and commercial-scale manufacturing has been achieved. |
|
|
We and our joint ventures and licensees may not be able to manufacture products based on our technologies successfully on a commercial scale. |
|
|
We and our joint ventures and licensees may experience performance problems with key suppliers or subcontractors. |
|
|
Other companies, many of which have greater resources than we have, may develop competing products or technologies which cause products based on our technologies to become obsolete or non-competitive. |
33
Table of Contents
|
|
Our ability to succeed will be dependent upon our ability to successfully implement our business plan, as to which no assurance can be given. |
|
|
We receive a significant portion of our revenues from a small number of customers. |
|
|
Adverse business or financial conditions affecting the automotive industry may have a material adverse effect on our Cobasys joint venture and our NiMH battery business. |
|
|
Our government product development and research contracts may be terminated by unilateral government action, or we may be unsuccessful in obtaining new government contracts to replace those which have been terminated or completed. |
|
|
The reduction or elimination of government incentives related to solar power could cause our revenues to decline. |
|
|
We may suffer the loss of key personnel or may be unable to attract and retain qualified personnel to maintain and expand our business. |
|
|
We may become subject to legal or regulatory proceedings which may reach unfavorable resolutions. |
|
|
We are subject to a variety of federal, state and local laws, rules and regulations related to the discharge or disposal of toxic, volatile or other hazardous chemicals. |
|
|
We are required to account for employee stock option plans using the fair value method, which will increase our net loss and net loss per share. |
|
|
We have disclosed a material weakness in our internal controls that, if not remedied, could result in material misstatements in our financial statements, cause investors to lose confidence in our reported financial information and have a negative effect on the trading price of our stock. |
|
|
Our ability to use net operating loss and tax credit carryforwards to offset taxable income is currently subject to limitations and may be subject to additional limitations. |
Risks Related to Our Intellectual Property
|
|
Our success depends in part upon our ability to protect our intellectual property and our proprietary technology. |
|
|
We rely on trade secrets and other confidential information to maintain our proprietary position. |
|
|
We may be involved in lawsuits to protect or enforce our patents, which could be expensive and time consuming. |
|
|
Third parties may own or control patents or patent applications that are infringed by our products or technologies. |
Risk Related to an Investment in Our Common Stock
|
|
Our stock price has been subject to significant volatility and your investment could suffer a decline in value. |
|
|
Our quarterly operating results may fluctuate significantly. |
|
|
Because we do not intend to pay dividends, you will not receive funds without selling shares and, depending on when you sell your shares, you may lose the entire amount of your investment. |
34
Table of Contents
|
|
Provisions in our certificate of incorporation and bylaws and Delaware law may delay or prevent an acquisition of our company. |
There is also the risk that we incorrectly analyze these risks or that strategies we develop to address them are unsuccessful.
The following discussion should be read in conjunction with the accompanying Quarterly Financial Information and Notes thereto and the Companys Annual Report on Form 10-K, as amended, for the year ended June 30, 2005 and is qualified in its entirety by the foregoing. The results of operations for the three months and nine months ended March 31, 2006 are not necessarily indicative of results to be expected in future periods.
Results of Operations
Three Months Ended March 31, 2006 compared to Three Months Ended March 31, 2005
Overview
The Company had a net loss of $5,626,000 on revenues of $26,957,000 in the three months ended March 31, 2006 compared to a net loss of $11,250,000 on revenues of $17,896,000 in the three months ended March 31, 2005.
Major changes in operating income (loss) were as follows:
|
|
United Solar Ovonics product sales increased 69% to $21,075,000 for 2006 compared to $12,495,000 for 2005. United Solar Ovonics gross profit increased to $4,991,000 for 2006 compared to gross profit of $1,282,000 for 2005. |
|
|
Royalties increased to $1,704,000 in 2006 from $670,000 in 2005 due to $690,000 recognized in 2006 from an advance royalty payment made in prior years by a licensee to ECD associated with a license agreement under which the licensee no longer had contractual obligation to make payments and a change in estimated royalties based upon a recent royalty report received from a licensee. |
|
|
During the three months ended March 31, 2006, there was $1,307,000 increase in the net cost of product development. |
For the three months ended March 31, 2005, the loss from discontinued operations was $305,000 and zero for the three months ended March 31, 2006.
The following table summarizes each of the Companys business segment's operating results (in thousands) for the three months ended March 31, 2006 and 2005.
35
Table of Contents
Revenues | Income (Loss) from Operations | |||||||||||
Segment | 2006 | 2005 | 2006 | 2005 | ||||||||
United Solar Ovonic | $ | 23,059 | $ | 14,425 | $ | 2,552 | $ | (1,052 | ) | |||
Energy Conversion Devices | 14,311 | 1,748 | (9,193 | ) | (9,164 | ) | ||||||
Ovonic Battery(1) | 1,811 | 2,308 | (891 | ) | (1,095 | ) | ||||||
Consolidating Entries | (12,224 | )(2) | (585 | ) | 78 | 25 | ||||||
Consolidated | $ | 26,957 | $ | 17,896 | $ | (7,454 | ) | $ | (11,286 | ) |
|
(1) |
Excludes discontinued operations. |
|
(2) |
Elimination of ECD product sales to construct the new 25MW for United Solar Ovonic. |
United Solar Ovonic Segment
Total revenues at United Solar Ovonic in 2006 increased by $8,634,000 primarily due to higher product sales. Product sales increased by 69% to $21,075,000 for 2006 from $12,495,000 for 2005. This increase was principally attributable to higher shipments of photovoltaic products ($8,345,000) and higher pricing ($235,000).
The United Solar Ovonic segment's operating income improved by $3,604,000 in 2006 versus 2005 primarily due to the significantly higher product sales and the impact of cost reductions in 2006.
Gross profit on United Solar Ovonics product sales was $4,991,000 (a record 23.7% gross profit margin) in 2006 compared to a gross profit of $1,282,000 (10.3%) in 2005 due to higher sales, lower materials cost, and improved absorption of fixed costs as United Solar Ovonics production has exceeded its full-rated capacity of 25MW annually in 2006. United Solar Ovonics gross profit has increased steadily for each of the past five quarters.
Revenues from product development agreements for the United Solar Ovonic segment in 2006 more than funded the cost of product development. Revenues from product development agreements increased by $44,000 and spending decreased by $322,000, resulting in an decrease of $366,000 in net cost of product development.
Three Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 1,080,000 | $ | 1,080,000 | ||||||||
Product development and research | 806,000 | 1,128,000 | ||||||||||
Total cost of product development | 1,886,000 | 2,208,000 | ||||||||||
Revenues from product development agreements | 1,974,000 | 1,930,000 | ||||||||||
Net cost (excess revenue) of product development | $ | (88,000 | ) | $ | 278,000 |
36
Table of Contents
The product development expenditures were used to fund the development of new products for space and airship applications and to develop lower-cost and higher-efficiency terrestrial products.
While product sales increased 69%, United Solar Ovonics operating, general and administrative expenses (net of allocations) increased by only $480,000 (23%) in 2006. $176,000 of the increase resulted from higher personnel costs and $61,000 from higher utility costs, both due to increased manufacturing and sales volumes. In addition, there were $230,000 in costs in 2006 associated with United Solar Ovonics expansion plans.
Energy Conversion Devices Segment
The increase in ECDs revenues was a result of higher product sales, consisting of machine building, which increased to $11,947,000 in the three months ended March 31, 2006 compared to $51,000 in the three months ended March 31, 2005 due to the increase in work performed in 2006 to construct the new 25MW production equipment for United Solar Ovonic. These sales were made to a consolidated subsidiary and are eliminated in consolidation.
The ECD segments operating loss in 2006 ($9,193,000) was comparable to 2005 ($9,164,000). The work performed for United Solar Ovonic was done at cost and did not impact ECDs operating profit.
ECDs revenues from product development agreements decreased in the three months ended March 31, 2006 to $1,309,000 from $1,476,000 in the three months ended March 31, 2005, due to less revenues on work performed by ECD on United Solar Ovonic's U.S. Air Force contract ($113,000 in 2006 versus $492,000 in 2005), partially offset by increased revenues on contracts with National Institute of Standards and Technology (NIST) ($575,000 in 2006 versus $500,000 in 2005) for work done in optical switching and developing manufacturing technology for organic light-emitting diodes (OLEDs).
Revenues from product development agreements for the ECD segment for the three months ended March 31, 2006 funded 18% of this segments cost of product development. Revenues from product development agreements decreased by $167,000 while spending increased by $717,000, principally in the hydrogen technology, resulting in an increase of $884,000 in net cost of product development.
Three Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 1,844,000 | $ | 2,201,000 | ||||||||
Product development and research | 5,325,000 | 4,251,000 | ||||||||||
Total cost of product development | 7,169,000 | 6,452,000 | ||||||||||
Revenues from product development agreements | 1,309,000 | 1,476,000 | ||||||||||
Net cost of product development | $ | 5,860,000 | $ | 4,976,000 |
Product development programs include work on the Ovonic Cognitive Computer technology, including a unique three-terminal device with high-speed high-current capabilities based on ECD's Ovonic threshold/memory technology. Additionally, since acquiring a 100%
37
Table of Contents
interest in Ovonic Hydrogen Systems and Ovonic Fuel Cell Company, ECD has continued the development of solid hydrogen storage systems and the Ovonic metal hydride fuel cell technologies at a reduced level. ECD is also continuing development of its machine division, photovoltaics, optical switching, and OLED manufacturing technologies.
ECDs royalties, consisting principally of optical memory royalties, were $734,000 in 2006 compared to $58,000 in 2005. The 2006 royalties included $690,000 related to advance royalty payments, made in prior years by a licensee to ECD, associated with a license agreement under which the licensee no longer has contractual obligations to make payments.
Other revenues are primarily related to insurance proceeds, services, facilities and miscellaneous administrative and laboratory and machine shop services provided to some of ECDs joint ventures. Other revenues were $313,000 in the three months ended March 31, 2006 up from $162,000 in the three months ended March 31, 2005. The increase in other revenues in 2006 was primarily due to an increase in machine shop revenue from United Solar Ovonic.
ECDs operating, general and administrative expenses (net of allocations) were $3,482,000 in 2006 compared to $3,433,000 in 2005. The increase in the net expense for 2006 was principally due to the expensing of stock options ($345,000) in 2006 as required by SFAS 123(R) (see Note L of Notes to Consolidated Financial Statements), partially offset by a reduction in 2006 for costs related to compliance with Sarbanes-Oxley requirements. As of March 31, 2006, the total unrecognized compensation cost related to nonvested stock grants was $1.3 million and the related weighted-average period over which it is expected to be recognized is approximately 1.4 years.
Ovonic Battery Segment
The decrease in Ovonic Batterys revenues was due to a reduction ($294,000) in revenues from product development agreements and a reduction ($436,000) in equipment sales revenue. Revenues related to the advanced product development agreement from Cobasys decreased from $461,000 to $178,000 as Cobasys staffed up to assume full responsibility for its product development activities and is no longer reliant on Ovonic Battery.
The Ovonic Battery segment had a decreased operating loss in the three months ended March 31, 2006 versus 2005. The loss from operations of $891,000 in the three months ended March 31, 2006 improved by $204,000 compared to the three months ended March 31, 2005.
Equipment sales revenues decreased to $62,000 in 2006 from $498,000 in 2005, related to Ovonic Battery contracts with Rare Earth Ovonic to provide battery-manufacturing equipment. As of March 31, 2006, the Company has recorded revenues equal to cash it has received under the contracts. Additional amounts are due the Company under the contracts but all amounts have been reserved as uncollectible and no revenues will be recorded until such time as cash is received. Nickel hydroxide sales decreased to $227,000 in 2006 from $456,000 in 2005 due to a temporary reduction in demand from Ovonic Batterys principal customer.
Revenues from product development agreements for the Ovonic Battery segment in the three months ended March 31, 2006 funded 6% of Ovonic Batterys cost of product development as it continues to develop its core technologies. Revenues from product
38
Table of Contents
development agreements decreased by $294,000 and spending increased by $493,000, resulting in an increase of $787,000 in net cost of product development.
Three Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 24,000 | $ | 433,000 | ||||||||
Product development and research | 2,626,000 | 1,724,000 | ||||||||||
Total cost of product development | 2,650,000 | 2,157,000 | ||||||||||
Revenues from product development agreements | 146,000 | 440,000 | ||||||||||
Net cost of product development | $ | 2,504,000 | $ | 1,717,000 |
Royalties from NiMH batteries for transportation applications increased to $309,000 in 2006, from $228,000 in 2005. Overall royalties increased by 58% to $969,000 in the three months ended March 31, 2006 from $612,000 in the three months ended March 31, 2005 due to receipt of $275,000 for past royalties from a consumer battery licensee.
Revenues from license and other agreements increased to $288,000 in the three months ended March 31, 2006 from $238,000 in the three months ended March 31, 2005. The 2006 and 2005 license fees include $238,000 for the amortization over 10.5 years of the $10,000,000 payment received in the settlement of the patent infringement disputes and counterclaims in consideration of the licenses granted and the agreement to cross license through December 31, 2014 (see Note B of Notes to Consolidated Financial Statements). In addition, in 2006 Ovonic Battery received consumer battery license fees from its Chinese licensees: $25,000 from Zhejian Kan Battery Co., Ltd. and $25,000 from Hunan Corun Hi-Tech Co., Ltd.
Patent expenses were incurred in 2006 and 2005 in connection with the protection of Ovonic Batterys United States and foreign patents covering its proprietary technologies. Total patent expenses increased to $335,000 in the three months ended March 31, 2006 from $293,000 in the three months ended March 31, 2005.
Ovonic Battery's operating, general and administrative expenses (net of allocations) were negative $176,000 in 2006 compared to $74,000 in 2005. The decrease was primarily due to a reduced allocation in 2006 from ECD and other reductions in costs.
Other Income/Expense
The $1,685,000 increase in other income (net) ($1,827,000 income in 2006 compared to $142,000 income in 2005) resulted primarily from higher interest income ($1,933,000 in 2006 compared to $409,000 in 2005) due to increased funds available for investment, resulting from proceeds from the sale of stock and higher interest rates.
Ovonyx is included in the ECD segment. This investment is not consolidated; it is accounted for using the equity method of accounting and, thus, no Ovonyx revenues or expenses are included in ECD's results of operations for 2006 and 2005. During the three months ended March 31, 2006, ECD recognized $105,000 in its equity in losses of investment in Ovonyx compared to zero recognized in the three months ended March 31, 2005.
39
Table of Contents
Nine Months Ended March 31, 2006 compared to Nine Months Ended March 31, 2005
Overview
The Company had a net loss of $17,827,000 in the nine months ended March 31, 2006 compared to a net income of $57,235,000 on revenues of $135,662,000 in the nine months ended March 31, 2005. In December 2004, the Company recognized a one-time non-cash license fee of $79,532,000 in connection with an expanded license granted to Cobasys. The net loss for the nine months ended March 31, 2005, without this one-time, non-cash license fee of $79,532,000 (recognized in December 2004), would have been $22,297,000. On a comparable basis, the net loss of $17,827,000 in the nine months ended March 31, 2006 decreased by $4,470,000 compared to the nine months ended March 31, 2005, excluding this one-time, non-cash license fee.
In addition to the aforementioned one-time, non-cash license fee of $79,532,000, other major changes in operating income (loss) were as follows:
|
|
United Solar Ovonics product sales increased 64% to $60,118,000 for 2006 compared to $36,707,000 for 2005. United Solar Ovonics gross profit increased to $12,983,000 for 2006 compared to a gross profit of $1,670,000 for 2005. |
|
|
Royalties decreased to $3,218,000 in 2006 from $3,746,000 in 2005 due to $1,811,000 recognized in 2005 from advance royalty payments made in prior years by licensees to Ovonic Battery and ECD, partially offset by $690,000 recognized in 2006, associated with license agreements under which the licensees no longer had contractual obligation to make payments. In addition, the Company received $275,000 in 2006 from an Ovonic Battery licensee for past royalties. |
|
|
Overall spending for product development and research decreased by $1,713,000 as a result of our restructuring program; however, funding decreased by $7,242,000 resulting in an increase of $5,530,000 in the net cost of product development. |
|
|
$2,266,000 extraordinary gain in 2005 due to payment received from Chevron in excess of restructuring costs (see Note E of Notes to Consolidated Financial Statements). |
|
|
$8,000,000 income in 2005 resulting from a distribution from our joint venture Cobasys related to a partial reimbursement of legal fees related to the MEI settlement (see Note B of Notes to Consolidated Financial Statements). |
|
|
$1,710,000 impairment loss in 2005 for Rare-Earth Ovonic. |
For the nine months ended March 31, 2006, the Company had a gain from discontinued operations of $314,000, and for the nine months ended March 31, 2005, the loss from discontinued operations was $1,141,000.
40
Table of Contents
The following table summarizes each of the Companys business segment's operating results (in thousands) for the nine months ended March 31, 2006 and 2005.
Revenues | Income (Loss) from Operations | |||||||||||
Segment | 2006 | 2005 | 2006 | 2005 | ||||||||
United Solar Ovonic | $ | 64,069 | $ | 43,008 | $ | 5,989 | $ | (3,590 | ) | |||
Energy Conversion Devices | 41,018 | 9,791 | (23,391 | ) | (18,966 | ) | ||||||
Ovonic Battery(1) | 6,358 | 84,457 | (2) | (3,659 | ) | 72,511 | (2) | |||||
Consolidating Entries | (36,955 | )(3) | (1,594 | ) | (240 | ) | 662 | |||||
Consolidated | $ | 74,490 | $ | 135,662 | $ | (21,301 | ) | $ | 50,617 |
|
(1) |
Excludes discontinued operations. |
|
(2) |
Includes a one-time, non-cash license fee of $79,532,000. |
|
(3) |
Elimination of ECD product sales to construct the new 25MW for United Solar Ovonic |
United Solar Ovonic Segment
Total revenues at United Solar Ovonic in 2006 increased by $21,061,000 primarily due to higher product sales. Photovoltaic product sales increased by 64% to $60,118,000 for 2006 from $36,707,000 for 2005. This increase was principally attributable to higher shipments of photovoltaic products ($18,816,000), sales of $4,015,000 recognized in the nine months ended March 31, 2006 for shipments physically shipped under DDP terms in the prior periods and higher pricing ($580,000).
The United Solar Ovonic segment's operating income improved by $9,579,000 in 2006 versus 2005 primarily due to the significantly higher product sales and the impact of cost reductions in 2006.
Gross profit on United Solar Ovonics product sales was $12,983,000 (a record 21.6% gross profit margin) in 2006 compared to a gross profit of $1,670,000 (4.5%) in 2005 because of higher sales, lower materials cost, and improved absorption of fixed costs in 2006.
United Solar Ovonics revenues from product development agreements in the nine months ended March 31, 2006 were $3,935,000 compared to $6,132,000 in 2005. The decrease in 2006 was principally due to lower revenues on the U.S. Air Force contract for the development of new products for space and airship applications due to a reduction in work performed on this contract in 2006 and a delay in the start up of the replacement contract with NREL ($156,000 in the nine months ended March 31, 2006 compared to $687,000 in the nine months ended March 31, 2005).
Revenues from product development agreements for the United Solar Ovonic segment in 2006 funded 79% of its cost of product development. Revenues from product development agreements decreased by $2,197,000 and spending decreased by $1,623,000, resulting in an increase of $574,000 in net cost of product development.
41
Table of Contents
Nine Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 2,491,000 | $ | 3,997,000 | ||||||||
Product development and research | 2,464,000 | 2,581,000 | ||||||||||
Total cost of product development | 4,955,000 | 6,578,000 | ||||||||||
Revenues from product development agreements | 3,935,000 | 6,132,000 | ||||||||||
Net cost of product development | $ | 1,020,000 | $ | 446,000 |
The product development expenditures were used to fund the development of new products for space and airship applications and to develop lower-cost and higher-efficiency terrestrial products.
While product sales increased 64%, United Solar Ovonics operating, general and administrative expenses (net of allocations) increased by only $1,000,000 (20%) in 2006. $280,000 of the increase resulted from higher personnel costs and $164,000 from higher utility costs, both due to increased manufacturing and sales volumes, and $292,000 due to increased legal and professional costs. In addition, there were $230,000 in costs in 2006 associated with United Solar Ovonics expansion plans.
Energy Conversion Devices Segment
The increase in ECDs revenues was a result of higher product sales, consisting of machine building and manufacturing, which were $36,301,000 in 2006 compared to $124,000 in 2005 with the increase in work performed to construct the new 25MW equipment for United Solar Ovonic. These sales were made to a consolidated subsidiary and are eliminated in consolidation.
The ECD segment had an increased operating loss in 2006, versus 2005, primarily due to a $4,089,000 decrease in the segments hydrogen development contract revenues.
ECDs revenues from product development agreements decreased in the nine months ended March 31, 2006 to $3,172,000 from $8,332,000 in the nine months ended March 31, 2005, due to less revenues from Ovonic Hydrogen Systems, which is now a wholly owned subsidiary of ECD, (zero in 2006 versus $4,089,000 in 2005), reduced revenues on contracts with NIST ($1,424,000 in 2006 versus $1,690,000 in 2005) for work done in optical switching and developing manufacturing technology related to OLEDs, and reduced revenues ($317,000 in 2006 versus $1,272,000 in 2005) on work performed by ECD on United Solar Ovonic's U.S. Air Force contract.
Revenues from product development agreements for the ECD segment for the nine months ended March 31, 2006 funded 16% of this segments cost of product development. Revenues from product development agreements decreased by $5,160,000 while spending decreased by $516,000, principally in the hydrogen technology, resulting in an increase of $4,644,000 in net cost of product development.
42
Table of Contents
Nine Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 4,166,000 | $ | 9,150,000 | ||||||||
Product development and research | 15,836,000 | 11,368,000 | ||||||||||
Total cost of product development | 20,002,000 | 20,518,000 | ||||||||||
Revenues from product development agreements | 3,172,000 | 8,332,000 | ||||||||||
Net cost of product development | $ | 16,830,000 | $ | 12,186,000 |
Product development programs include work on the Ovonic Cognitive Computer technology, including a unique three-terminal device with high-speed high-current capabilities based on ECD's Ovonic threshold/memory technology. Additionally, since acquiring a 100% interest in Ovonic Hydrogen Systems and Ovonic Fuel Cell Company, ECD has continued the development of solid hydrogen storage systems and the Ovonic metal hydride fuel cell technologies at a reduced level. ECD is also continuing development of its machine division, photovoltaics, optical switching, and OLED manufacturing technologies.
ECDs royalties, consisting principally of optical memory royalties, were $834,000 in 2006 compared to $786,000 in 2005. The 2006 royalties included $690,000 and the 2005 royalties included $686,000 related to advance royalty payments, made in prior years by a licensee to ECD, associated with a license agreement under which the licensee no longer has contractual obligations to make payments.
Other revenues are primarily related to insurance proceeds, services, facilities and miscellaneous administrative and laboratory and machine shop services provided to some of ECDs joint ventures. Other revenues were $684,000 in the nine months ended March 31, 2006 up from $550,000 in the nine months ended March 31, 2005. The increase in other revenues in 2006 was primarily due to an increase in laboratory services for Ovonyx.
ECDs operating, general and administrative expenses (net of allocations) were $6,937,000 in 2006 compared to $5,856,000 in 2005. The increase in the net expense for 2006 was principally due to expenses of $1,145,000 of the total consolidated expense of $1,287,000 recorded in 2006 in connection with the adoption of SFAS 123(R) (see Note L of Notes to Consolidated Financial Statements) and an increase of $457,000 in 2006 for the costs associated with nonemployee stock options, partially offset by a reduction in 2005 for costs related to compliance with Sarbanes-Oxley requirements. As of March 31, 2006, the total unrecognized compensation cost related to nonvested stock grants was $1.3 million and the related weighted-average period over which it is expected to be recognized is approximately 1.4 years.
Ovonic Battery Segment
The decrease in Ovonic Batterys revenues was primarily due to the fact that in December 2004 Ovonic Battery recognized a one-time, non-cash license fee of $79,532,000.
The Ovonic Battery segment had an increased operating loss in the nine months ended March 31, 2006 versus 2005. In December 2004, Ovonic Battery recognized a one-time, non-cash license fee of $79,532,000 in connection with expanding the scope of the license granted
43
Table of Contents
to Cobasys. The loss from operations for the nine months ended March 31, 2005, without this one-time, non-cash license fee of $79,532,000, would have been $7,021,000. On a comparable basis, the loss from operations of $3,659,000 in the nine months ended March 31, 2006 improved by $3,362,000 compared to the nine months ended March 31, 2005, excluding this one-time, non-cash license fee. In addition, $1,125,000 in royalties was recognized in the nine months ended March 31, 2005 see Note H of Notes to Consolidated Financial Statements.
Equipment sales revenues increased to $780,000 in 2006 from negative $1,100,000 in 2005, related to Ovonic Battery contracts with Rare Earth Ovonic to provide battery-manufacturing equipment. As of March 31, 2006, the Company has recorded revenues equal to cash it has received under the contracts. Additional amounts are due the Company under the contracts but all amounts have been reserved as uncollectible and no revenues will be recorded until such time as cash is received. Nickel hydroxide sales were $1,491,000 in 2006 and $710,000 in 2005.
Revenues from product development agreements for the Ovonic Battery segment in the nine months ended March 31, 2006 funded 10% of Ovonic Batterys cost of product development as it continues to develop its core technologies. Revenues from product development agreements decreased by $788,000 and spending decreased by $476,000, resulting in an increase of $312,000 in net cost of product development.
Nine Months Ended March 31, |
||||||||||||
2006 | 2005 | |||||||||||
Cost of revenues from product development agreements | $ | 311,000 | $ | 1,479,000 | ||||||||
Product development and research | 6,735,000 | 6,043,000 | ||||||||||
Total cost of product development | 7,046,000 | 7,522,000 | ||||||||||
Revenues from product development agreements | 719,000 | 1,507,000 | ||||||||||
Net cost of product development | $ | 6,327,000 | $ | 6,015,000 |
Royalties from NiMH batteries for transportation applications increased to $951,000 in 2006, up from $735,000 in 2005. Overall royalties decreased by 19% to $2,384,000 in the nine months ended March 31, 2006 from $2,961,000 in the nine months ended March 31, 2005 due to the recognition in 2005 of $1,125,000 related to an advance royalty payment made by a licensee to Ovonic Battery in 1993 associated with a license agreement under which the licensee no longer has a contractual obligation to make payments, partially offset by the increase in royalties for transportation applications and the receipt of $275,000 for past royalties from a consumer battery licensee.
Revenues from license and other agreements decreased to $784,000 in the nine months ended March 31, 2006 from $80,246,000 in the nine months ended March 31, 2005. In December 2004, Ovonic Battery recognized a one-time, non-cash license fee of $79,532,000 in connection with an expanded license granted to Cobasys. The 2006 and 2005 license fees include $714,000 for the amortization over 10.5 years of the $10,000,000 payment received in the settlement of the patent infringement disputes and counterclaims in consideration of the licenses granted and the agreement to cross license through December 31, 2014 (see Note B of Notes to Consolidated Financial Statements). In addition, in 2006 Ovonic Battery received consumer battery license fees from its Chinese licensees: $20,000 from Intellect Battery Co.,
44
Table of Contents
Ltd., $25,000 from Zhejian Kan Battery Co., Ltd. and $25,000 from Hunan Corun Hi-Tech Co., Ltd.
Patent expenses were incurred in 2006 and 2005 in connection with the protection of Ovonic Batterys United States and foreign patents covering its proprietary technologies. Total patent expenses decreased to $968,000 in the nine months ended March 31, 2006 from $1,105,000 in the nine months ended March 31, 2005.
Ovonic Battery's operating, general and administrative expenses (net of allocations) were negative $386,000 in 2006 compared to $615,000 in 2005. The decrease was due to a reduced allocation in 2006 from ECD and other reductions in costs.
Other Income/Expense
The $3,161,000 decrease in other income (net) ($3,159,000 income in 2006 compared to $6,320,000 income in 2005) resulted primarily from an $8,000,000 distribution from joint venture in 2005 related to a partial reimbursement of legal fees related to the MEI settlement, partially offset by higher interest income ($3,530,000 in 2006 compared to $595,000 in 2005) due to increased funds available for investment and higher interest rates and an impairment loss of $1,710,000 in Rare Earth Ovonic-China in 2005.
Ovonyx is included in the ECD segment. This investment is not consolidated; it is accounted for using the equity method of accounting and, thus, no revenues or expenses of Ovonyx are included in ECD's results of operations for 2006 and 2005. During the nine months ended March 31, 2006, ECD recognized $150,000 in its equity in losses of investment in Ovonyx compared to $100,000 recognized in the nine months ended March 31, 2005.
Critical Accounting Policies
Effective July 1, 2005, ECD adopted SFAS No. 123(R), "Share-Based Payment" ("SFAS No. 123(R)"). This statement replaces SFAS No. 123, "Accounting for Stock-Based Compensation" ("SFAS No. 123") and supersedes APB No. 25. SFAS No. 123(R) requires that all stock-based compensation be recognized as an expense in the financial statements and that such cost be measured at the fair value of the grant. This statement was adopted using the modified prospective method of application, which requires us to recognize compensation expense on a prospective basis. Therefore, prior period financial statements have not been restated. Under this method, in addition to reflecting compensation expense for new share-based grants, expense is also recognized to reflect the remaining service period of grants that had been included in pro-forma disclosures in prior periods. SFAS No. 123(R) also requires that excess tax benefits (none for ECD due to tax losses) related to stock option exercises be reflected as financing cash inflows instead of operating cash inflows.
With the adoption of SFAS No. 123(R), ECD is required to record the fair value of stock-based compensation grants as an expense. In order to determine the fair value of stock options on the date of grant, ECD applies the Black-Scholes option-pricing model. Inherent in this model are assumptions related to expected stock-price volatility, option life, risk-free interest rate and dividend yield. While the risk-free interest rate and dividend yield are less subjective assumptions, typically based on factual data derived from public sources, the expected stock-price volatility, forfeiture rate and option life assumptions require a greater level of judgment which make them critical accounting estimates.
45
Table of Contents
ECD uses an expected stock-price volatility assumption that is based on historical implied volatilities of the underlying stock which is obtained from public data sources. There were no stock option grants during the three months and nine months ended March 31, 2006.
With regard to the weighted-average option life and forfeiture rate assumptions, ECD considers the behavior of past grants and models the pattern of aggregate exercises and forfeitures. Patterns are determined on specific criteria of the aggregate pool of optionees. There were no stock option grants during the three months and nine months ended March 31, 2006.
In October 2005, the Financial Accounting Standards Board issued FASB Staff Position (FSP) No. FAS 123(R)-2, "Practical Accommodation to the Application of Grant Date as defined in FASB Statement No. 123(R)," to provide guidance on determining the grant date for a grant as defined in SFAS No. 123(R). This FSP stipulates that assuming all other criteria in the grant date definition are met, a mutual understanding of the key terms and conditions of a grant to an individual employee is presumed to exist upon the grant's approval in accordance with the relevant corporate governance requirements, provided that the key terms and conditions of a grant (a) cannot be negotiated by the recipient with the employer because the award is a unilateral grant, and (b) are expected to be communicated to an individual recipient within a relatively short time period from the date of approval. ECD has applied the principles set forth in this FSP upon its adoption of SFAS No. 123(R).
Liquidity and Capital Resources
As of March 31, 2006, the Company had $386,944,000 consolidated cash, cash equivalents and short-term investments (consisting of money market funds, certificates of deposit and corporate notes, classified as available-for-sale, maturing from one day to six months). Consolidated working capital was $407,760,000.
In March 2006, ECD completed its previously announced public offering of 7,000,000 shares of common stock, including 6,616,928 shares sold by ECD and 383,072 shares sold by certain directors and officers. ECD received gross proceeds of approximately $324.2 million, $307.5 net after underwriting discounts and commissions and expenses payable by ECD, from the sale of the 6,616,928 shares of common stock.
ECD did not receive any proceeds from the sale of the 383,072 shares sold by certain directors and officers in connection with this offering, other than the aggregate option exercise price of approximately $5.1 million relating to such shares. Following the completion of the offering, each of the directors and officers continue to own shares equal to or greater than the number of shares owned prior to the public offering.
In April 2006, the underwriters of ECDs public offering of 7,000,000 shares of ECD Common Stock (completed on March 7, 2006) exercised their over-allotment option in full and purchased an additional 1,050,000 shares. As a result, ECD received an additional $51.4 million in gross proceeds from the exercise of the over-allotment option, before underwriting discounts and commissions and expenses payable by it, bringing the total gross proceeds to ECD from the offering to approximately $375.6 million.
46
Table of Contents
In January 2006, ECD received proceeds of $21,445,000 in connection with the exercise of warrants to purchase 1,337,792 shares of ECD Common Stock by a purchaser of units in the private placements of November 2003 and January 2004.
Our strategy is to transition from a highly successful research-oriented company to the next phase of development, which is to commercialize the products we have developed, increase manufacturing capacity of our United Solar Ovonic subsidiary and concentrate on growing sales revenues and equity value in our core commercial businesses United Solar Ovonic, Cobasys and Ovonyx. The Company intends to continue its efforts to secure funding to finance its hydrogen, fuel cell and other technologies.
In March 2006, ECD announced the plan to expand United Solar Ovonic's module manufacturing capacity to 300 megawatts (MW) by 2010. The first phase of the expansion plan includes the construction of the Greenville manufacturing facility with an annual capacity of 50MW, which is expected to be operational in calendar year 2007. In the near term, the Company expects to use approximately $150 million of the net proceeds from the March 2006 equity offering for this phase of the expansion plan. The Company will use the balance of the net proceeds from the equity offering for future capacity expansion of its Ovonic solar cell business and for other general corporate purposes.
The commercialization of ECD's Ovonic Unified Memory through the Ovonyx corporation does not require financial support because Ovonyx has generated sufficient funds for its operations through licensing activities. In December 2005, Ovonyx and Samsung entered into a long-term, royalty-bearing license agreement for Ovonyx intellectual property relating to the OUM thin-film semiconductor memory technology.
The commercialization of NiMH battery systems by the Cobasys joint venture does not currently require financial support due to the mechanism for additional funding by Chevron reached in December 2004 which provides for Chevron to continue funding the Cobasys expansion. Chevron will be entitled to priority right of repayment for providing the additional funding. ECD and Chevron will each continue to own a 50% interest in Cobasys subject to adjustment under certain circumstances.
The Company expects the amount of cash to be received under existing product development agreements in the year ending June 30, 2006 to decrease to approximately $10,574,000, compared to $21,015,000 received in the year ended June 30, 2005, due to reduced funding to be received in the year ending June 30, 2006 from Chevron, Cobasys and the U.S. Air Force programs.
Our current backlog of orders for machine-building and equipment sales contracts and photovoltaic products is $57,538,000 (of which we expect to recognize $24,103,000 in fiscal 2006) compared to a backlog of $52,059,000 at June 30, 2005. The backlog includes $57,538,000 at March 31, 2006 and $51,299,000 at June 30, 2005 at United Solar Ovonic.
During the nine months ended March 31, 2006, $17,701,000 of cash was used in operating activities. The difference between the net loss of $17,827,000 and the net cash used in operations was principally due to increased uses of cash increases in accounts receivable ($4,412,000), inventories ($3,123,000) and other assets ($1,430,000) partially offset by increased sources of cash depreciation and stock issued for services rendered, including
47
Table of Contents
$1,287,000 for stock-based compensation expense recognized in connection with the adoption of SFAS 123(R), and an increase in accounts payable and accrued expenses ($4,003,000).
The Company spent $40,447,000 on property, plant and equipment during the nine months ended March 31, 2006, principally for United Solar Ovonic's manufacturing expansion. In total, the Company expects to spend $51,000,000 for capital expenditures in fiscal 2006, primarily to double United Solar Ovonic's capacity to manufacture solar modules and for leasehold improvements to the Company's facilities.
The Company is also in discussions with potential partners to fund its various activities, including its hydrogen, information and fuel cell programs. No assurances can be given as to the timing or success of the aforementioned plans, negotiations, discussions and programs. Management believes that existing cash and cash equivalents will be adequate to support and finance planned growth, operations, capital expenditures and company-sponsored product development programs over the coming year.
The Company does not have any off-balance sheet arrangements at March 31, 2006.
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
The following discussion about our exposure to market risk of financial instruments contains forward-looking statements. Actual results may differ materially from those described.
Our holdings of financial instruments are comprised of debt securities and time deposits. All such instruments are classified as securities available-for-sale. We do not invest in portfolio equity securities, or commodities, or use financial derivatives for trading purposes. Our debt security portfolio represents funds held temporarily, pending use in our business and operations. The Company had $386,939,000 and $95,805,000 of these investments (including cash equivalents) on March 31, 2006 and June 30, 2005, respectively. On March 31, 2006, the investments had an average maturity of 42 days. It is the Companys policy that investments (including cash equivalents) shall be rated A or higher by Moody's or Standard and Poors, no single investment (excluding cash equivalents) shall represent more than 10% of the total portfolio and at least 10% of the total portfolio shall have maturities of 90 days or less. Our market risk primarily relates to the risks of changes in the credit quality of issuers. An interest rate change of 1% would result in a change in the value of our March 31, 2006 portfolio of approximately $327,000.
48
Table of Contents
Item 4. |
Controls and Procedures |
|
A. |
Evaluation of Disclosure Controls and Procedures |
As of June 30, 2005, we evaluated our disclosure controls and procedures under the direction of our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Companys disclosure controls and procedures were not effective as of June 30, 2005. This conclusion was reached solely due to a material weakness resulting from a failure to ensure the correct application of SEC Staff Accounting Bulletin No. 104 Revenue Recognition when the revenue from sale transactions with certain of our international customers was initially recognized in a manner that was inconsistent with the shipping terms of Delivered Duty Paid.
We are confident that, as of March 31, 2006, we have fully remediated the material weakness in our internal control over financial reporting with respect to accounting for these sale transactions. The remedial actions included:
|
|
Improved training, education and accounting reviews designed to ensure that all relevant personnel involved in sale transactions understand and apply proper revenue recognition accounting in compliance with SEC Staff Accounting Bulletin No. 104 Revenue Recognition; and |
|
|
Reviewing all shipping terms, other than FOB shipping point, to ensure proper revenue recognition with current contracts; and |
|
|
Adding controls around changes to shipping terms, other than FOB shipping point, and monitoring shipping terms periodically; and |
|
|
Reviewing all new contracts to ensure that proper revenue recognition occurs. |
As of March 31, 2006, an evaluation was carried out under the supervision of the Chief Executive Officer and Chief Financial Officer of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-14(c) under the Securities Exchange Act of 1934). Based upon that evaluation, which considered the material weakness and the remediation set forth above, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.
49
Table of Contents
PART II - OTHER INFORMATION
Item 6. |
Exhibits |
|
A. |
Exhibits |
31.1 |
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2 |
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32 |
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
50
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ENERGY CONVERSION DEVICES, INC. |
|
|
Date: May 10, 2006 |
By: /s/ Stephan W. Zumsteg |
|
|
Date: May 10, 2006 |
By: /s/ Robert C. Stempel |
51